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ABSTRACT 
Age-related macular degeneration (AMD) and age-related cataract (cataract) are two of 
the leading causes of vision impairment and blindness in the U.S. (Prevent Blindness America, 
2002). The rate of vision impairment and blindness is expected to double in the next 30 years. 
Lutein and/or high-dose antioxidants reduce(s) the risk of AMD or improve(s) visual function in 
patients with AMD (Seddon, Ajani, et al., 1994; Age-Related Eye Disease Study Group [AREDS 
Group], 2001a; Richer et al., 2004). 
The purpose of this study was to determine the perceptions, recommendations, and 
educational or informational materials of optometrists on lutein and zeaxanthin and eye health. A 
20-item survey was developed and mailed to 300 randomly chosen licensed optometrists in 
Wisconsin. The response rate was 42.3%. 
Most respondents (77.2%) were moderately to very informed about the relationship 
between lutein and zeaxanthin and eye health. The information on lutein and zeaxanthin and eye 
health was adequate for 78.0% of respondents to make recommendations to patients, A multi- 
vitamidmineral supplement was the most recommended supplement (9 1.3%) with a lutein or 
zeaxanthin supplement (86.6%), spinach or other foods rich in lutein and zeaxanthin (85.8%), 
and a zinc supplement (85.0%) following closely behind. Most respondents distributed 
educational or informational materials to patients at their practice (79.5%) while about half 
(50.5%) of these respondents had educational or informational materials on lutein and 
zeaxanthin. 
An increased demand fiom patients and insurers to provide nutrition education is 
anticipated. Patient educational materials or dietitian referrals are key strategies to provide this 
education. Future research should address the barriers of optometrists in obtaining information 
on nutrition for eye health. 
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Chapter I: Introduction 
Vision impairment and blindness due to age-related eye disease is increasing (Prevent 
Blindness America, 2002). Age-related macular degeneration (AMD) is the leading cause of 
blindness in persons age 60 and older in the U.S. while cataract is the leading cause of blindness 
in the world (National Eye Institute [NEI], 2002, March). Blindness negatively affects both an 
individual's quality of life and the national economy (Prevent Blindness America). The 
carotenoids lutein and zeaxanthin may play a preventive role in age-related blindness as 
discussed below. 
Lutein and zeaxanthin are the only two carotenoids concentrated in the macula 
(Snodderly, 1995) and lens of the eye (Yeum, Taylor, Tang, & Russell, 1995). These two yellow 
plant pigments are called the macular pigment (Pratt, 1999). Macular pigment density (MPD) is 
positively associated with visual acuity (Hammond, Wooten, & Snodderly, 1998) and inversely 
associated with lens optical density (LOD) (Berendschot et al., 2002). Studies have shown that 
MPD can be increased through diet (Harnmond, Johnson, et al., 1997) or supplementation 
(Landrum et al., 1997; Berendschot et al., 2000). A higher dietary intake of spinach or collard 
greens, foods rich in lutein and zeaxanthin, has been associated with a lower risk of AMD 
(Seddon, Ajani, et al., 1994). Brown et al. (1 999) and Chasm-Taber et al. (1 999) found a 1 9% 
and 22% lower risk for cataract extraction in men and women, respectively for those with the 
highest intake of lutein and zeaxanthin intake compared to those in the lowest quintile. 
In addition to reducing the risk of AMD and cataract, lutein, zeaxanthin andfor 
antioxidants have reduced the risk of progression to advanced AMD (AREDS Group, 2001a) and 
have improved visual acuity in AMD patients (Richer et al., 2004). This has led to the 
manufacture of lutein and zeaxanthin as a dietary supplement (Kreuzer, n.d.) and to lutein as the 
most popular herbal and other natural dietary supplement mainly in the form of a multi-vitamin 
preparation (Kelly et al., 2005). 
Natural sources of lutein and zeaxanthin include kale, collard greens and spinach as the 
highest sources (United States Department of Agriculture [USDA], n.d.). Healthy People 201 0 
(Food and Drug Administration [FDA] & National Institutes of Health [NIH], 2000) and The 
Dietary Guidelines for Americans (United States Department of Health and Human Services 
[USDHHS], 2005) both recommend frequent consumption of dark green vegetables. Despite the 
5 A Day guidelines (National Cancer Institute [NCI], 2001), most Americans are not meeting the 
recommended number of h i t  and vegetable servings (Centers for Disease Control and 
Prevention [CDC], 2006; FDA & NIH). The Multi-Center Eye Disease Case-Control Study 
found a median intake of 1.7 mg lutein per day (Seddon, Ajani, et al., 1994) while 6 mg per day 
has been shown to reduce risk for AMD (Mares-Perlman et al., 2001). The increasing rate of 
AMD and cataract may possibly be affected by the low consumption of dark green vegetables 
with lutein and zeaxanthin. 
Although the role of lutein in prevention of age-related eye disease is still uncertain (NEI, 
2002, July), optometrists can promote the intake of dark green vegetables as it is a national 
public health objective (FDA & NIH, 2000). With their expertise in eye care, optometrists are 
uniquely positioned to provide nutrition education for eye health. They may also provide credible 
information to guide patients on the use of nutritional supplements for eye health. With 
optometrists' lack of financial incentive and time for preventive health care, educational or 
informational materials or a referral to a dietitian may be an effective way to promote a healthy 
diet and address patient nutritional concerns. 
Statement of  the Problem 
Studies showing a relationship between diets high in lutein and zeaxanthin and eye health 
along with an increased popularity of lutein supplements have provided a challenge for 
optometrists to take on a non-traditional role of nutrition education. The purpose of this study 
was to describe how the confidence of licensed Wisconsin optometrists in the relationship 
between diets high in lutein and zeaxanthin and eye health influenced their clinical practice. 
First, this study was conducted to gain an understanding of how optometrists viewed the current 
state of literature on nutrition and eye health. Secondly, since it is most likely that patients would 
seek out nutrition advice for eye health from their eye doctor, knowing the nutritional 
recommendations of optometrists can assist patients in obtaining credible information. Third, 
patient educational materials can compliment advice given in the office. Assessing the 
availability and perceived importance of educational materials can help public health 
professionals determine the need to develop these materials. 
Research Objectives 
The specific research objectives were to: 
1. Evaluate the awareness, sources of information, and confidence of Wisconsin 
optometrists on the relationship between diets high in lutein and zeaxanthin and eye 
health; 
2. Determine the nutritional recommendations of Wisconsin optometrists for the 
prevention or treatment of AMD and cataract; 
3. Assess the availability and importance of educational materials on lutein and 
zeaxanthin to Wisconsin optometrists; 
4. Summarize the perceptions of Wisconsin optometrists of lutein and zeaxanthin and 
eye health; and 
5. Describe the demographic characteristics of Wisconsin optometrists. 
Assumptions o f  the Study 
It was assumed that optometrists who completed the survey were honest in their 
responses and that their answers reflected their current practices and feelings. 
Definition of Terms 
Snellen Chart: Chart containing rows of letters, numbers or symbols of a standardized 
size used to test visual acuity usually at 20 feet (Triad Publishing Company, 2006). 
20/20 vision: Normal sharpness or clarity of vision (visual acuity) at a distance of 20 feet. 
This is only one indictor of visual function. Other indicators include side vision, eye 
coordination, depth perception, focusing ability and color vision (American Optometric 
Association [AOA], 2006b). 
Vision impairment: Vision of 20140 or worse in the better eye with best correction 
(Prevent Blindness America, 2002) often referred to as low vision (The Eye Diseases 
Prevalence Research Group [EDPRG], 2004a). 
Legal blindness: In the United States, vision of 201200 in the better eye with best 
possible correction (AOA, 2006a). 
Age-related eye disease (ARED): The main causes of vision impairment and blindness in 
the U.S., which includes age-related macular degeneration, cataract, diabetic retinopathy 
and glaucoma (Prevent Blindness America, 2002). 
Age-related macular degeneration (AMD): A degenerative disorder of the retina at the 
area of highest concentration of photoreceptors (macula), which leads to legal blindness 
(Snodderly, 1995). 
Age-related cataract: The opacification and dysfunction of the lens of the eye from the 
accumulated effects of photooxidation and aging (Taylor, Jacques, & Epstein, 1995). 
Limitations of the Study 
This study was limited by the optometrists who chose to respond to the survey and the 
design of the survey questions. The responses received may not accurately represent the practices 
and feelings of licensed Wisconsin optometrists overall. Data may be biased toward optometrists 
who feel strongly in favor of lutein supplements. While the Age-Related Eye Disease Study 
(AREDS), a major eye study in which optometrists are likely to base their nutritional 
recommendations, evaluated the effect of high-dose vitamins and minerals taken together on the 
progression of AMD and age-related cataract, the survey asked about these nutrients individually 
and did not separate recommendations for patients at different stages of AMD. 
Methodology 
A 20-item survey was developed after review of the literature on lutein and zeaxanthin, 
antioxidants, AMD and cataract. The survey was pre-tested by three licensed optometrists. The 
survey was mailed to 300 randomly chosen licensed optometrists in Wisconsin in May 2003. 
Data were entered and analyzed using SPSS version 1 1.5 for Windows. 
Chapter 11: Literature Review 
Introduction 
This chapter will discuss lutein and zeaxanthin in age-related eye disease (ARED). The 
first section will describe the occurrence of visual impairment, blindness, age-related macular 
degeneration (AMD) and cataract. The next section will review the current observational and 
clinical research on lutein and zeaxanthin in AMD and cataract. The last section will examine 
lutein and zeaxanthin in foods or supplements and factors that may influence their digestion and 
safety. 
Vision Impairment, Blindness and Age-Related Eye Disease 
An estimated 3.4 million Americans age 40 and older (2.9%) are visually impaired while 
more than one million of this group (0.9%) is considered legally blind (Prevent Blindness 
America, 2002). Women are affected more by vision impairment and blindness than men. 
Approximately 3.5% of women and 2.1% of men age 40 and older in the United States are 
visually impaired while 1.1% of women and 0.6% of men are blind. There is a higher incidence 
of vision impairment in the White race (3.1%) compared to the Black (2.2%), Hispanic (1.9%) or 
other races (1.8%). When the percent of the total cases of vision impairment due to blindness is 
compared by race, Blacks are the most affected by blindness (42.2%) and Hispanics are the least 
affected (1 3.6%). Vision impairment and blindness tends to increase considerably after age 75. 
The rate of vision impairment and blindness is expected to double in the next 30 years due to the 
aging Baby Boomer generation. 
The above rates of vision impairment and blindness may appear small while blindness 
among races may appear high. To better understand these statistics, it should be noted that the 
reported rates of vision impairment include the total U.S. population age 40 and older who have 
vision of 20140 or worse in the better eye even after correction. Similarly, the reported rates of 
blindness include the total population age 40 and over who are legally blind. In contrast, the 
reported rates of blindness among races include only blind persons age 40 and older in the U.S. 
Therefore, the rates of vision impairment and blindness may seem low because of less vision 
impairment and blindness among the middle aged (age 40 to 70) while the rates of blindness may 
appear elevated among races because these are expressed as percentage of the total blind rather 
than percentage of the total race age 40 and older. 
The four leading causes of vision impairment and blindness in the U.S. are AMD, 
cataract, diabetic retinopathy and glaucoma (Prevent Blindness America, 2002). These 
conditions are collectively referred to as ARED. This paper will concentrate on AMD and 
cataract. When speaking of cataract, age-related cataract is assumed. AMD is the main cause of 
blindness in persons age 60 and older in the United States while cataract is the primary cause of 
blindness in the world (NEI, 2002, March). 
Blindness from AMD and cataract affects quality of life by restricting one's ability to 
read, write, drive a car and perform other activities of daily living. Brody et al. (2001) found 
32.5% of participants with late AMD (20160 vision) have depression, which was twice the rate of 
community-dwelling older adults. Vision loss also affects the national economy. It is expected 
that the federal government will lose four billion dollars annually in benefits and taxable income 
due to blindness and vision impairment (Prevent Blindness America, 2002). 
Age-Related Macular Degeneration (AMD) 
The two forms of AMD are dry AMD and wet AMD (Prevent Blindness America, 2002). 
The most common form, dry AMD, usually progresses slowly in the early stage (Gottlieb, 2002). 
Early dry AMD is characterized by fatty, yellow deposits called drusen (Prevent Blindness 
America) within the macula that are large and numerous (Gottlieb). The macula is the central 
area of the retina with the highest concentration of light-receptor cells, which provides sharp 
central vision. Late stage dry AMD involves atrophy of the retinal pigment epithelium 
(geographic atrophy), which can cause loss of central vision. While only about 15% of AMD 
cases are the wet form (Gottlieb), all of these are considered late stage because of the severe 
vision loss due to the growth of new blood vessels (neovascularization) that leak and form scar 
tissue (Prevent Blindness America). 
Approximately 1.6 million Americans age 50 and older (2.2%) have late AMD (Prevent 
Blindness America, 2002; "U.S. Census 2000"). Females (2.5%) are affected slightly more than 
males (1.7%). The incidence of late AMD in Wisconsin is estimated at 2.4% with 2.9% of 
females and 1.9% of males affected, which is slightly higher than the national rate. The Beaver 
Dam, Wisconsin population had a prevalence of late AMD of 1.6% among persons age 43 to 86 
years (Klein, Klein, & Linton, 1992). Late AMD is most common in the White race (2.4%) 
followed by Blacks (l.4%), Hispanics (1.2%) and other races (1.2%). The Eye Diseases 
Prevalence Research Group (EDPRG, 2004a) found AMD to be the leading cause of blindness in 
White Americans. 
The rates of AMD are better understood when data are summarized by age, gender, and 
race (See Table 1). According to The Eye Diseases Prevalence Research Group (2004b) data, 
females have a higher rate of advanced ANID than males of the same race. Although black 
females have a higher rate in the earlier years (ages 50 to 69), white females have a higher rate in 
the later years (ages 70 to 2 80). This is due to a sharp increase among white females beginning 
at age 70 compared to black females who have a more moderate increase with age. Similarly, 
white males show a pattern of sharp increase of advanced AMD beginning at age 70 in contrast 
to black males who continue with a gradual increase with age. 
Table 1 
Prevalence of advanced age-related macular degeneration 
(AMD) by age, gender and race 
Rate Der 100 individuals (95% CI) 
L 
GenderIAge, years White Race ~ i a c k  ~ a c k  
Females 
50-54 0.20 (0.17-0.24) 0.68 (0.57-0.80) 
55-59 0.22 (0.20-0.24) 0.82 (0.71-0.96) 
60-64 0.35 (0.33-0.39) 1 .OO (0.86-1.15) 
65-69 0.70 (0.64-0.76) 1.21 (1.04-1.42) 
70-74 1.52 (1.4.1-1.64) 1.47 (1.23-1.76) 
75-79 3.44 (3.22-3.69) 1.79 (1.45-2.21) 
> 80 16.39 (14.97-17.91) 2.44 (1.85-3.20) 
Males 
50-54 0.34 (0.23-0.50) 0.42 (0.25-0.70) 
55-59 0.41 (0.34-0.50) 0.52 (0.33-0.80) 
60-64 0.63 (0.53-0.75) 0.63 (0.42-0.95) 
65-69 1.08 (0.91-1.29) 0.77 (0.50-1.18) 
70-74 1.98 (1.69-2.32) 0.93 (0.57-1.53) 
75-79 3.97 (3.18-4.24) 1.14 (0.63-2.05) 
2 80 1 1.90 (9.78-14.41) 1.56 (0.72-3.35) 
Note. Adapted from EDPRG, 2004b. 
The primary cause of AMD is still unknown (Prevent Blindness America, 2002) but risk 
factors include old age, female sex, white race, cigarette smoking, and low dietary intake of 
carotenoids (Gottlieb, 2002). Currently, there is no treatment to prevent or cure AMD but laser 
therapy has been shown to delay vision loss in some patients at risk for wet AMD. 
Age-Related Cataract (Cataracr) 
The lens of the eye is naturally clear but aging, exposure to sunlight, cigarette smoking, 
diet or alcohol consumption may lead to the clouding of the lens called age-related cataract 
(Prevent Blindness America, 2002). Cataracts can be classified by type, extent, and density 
including cortical, posterior sub-capsular, and nuclear (West, 1991). Unlike AMD, a widely 
accepted treatment has been found for cataract, which involves removal of the natural lens of the 
eye and replacement with an artificial implant (Prevent Blindness America). Medicare spends an 
estimated 3.4 billion dollars a year in treating cataract. Cataract extraction is the most common 
surgical procedure in the U.S. with more than two million procedures per year ("Nutrition & 
Cataracts," n.d.). Although cataract surgery has become quite common, cataract still remains a 
primary cause of vision impairment and blindness in those with barriers to accessing appropriate 
eye care, especially those in developing countries (West). 
Cataract affects about 20.5 million Americans age 40 and older (1 7.2%) (Prevent 
Blindness America, 2002). Prevalence is higher in females (20.0%) than males (13.9%). The 
incidence of cataract in Wisconsin is estimated to be 17.9% with 20.9% of females and 14.6% of 
males affected. Whites have the highest rate of cataract (1 8.5%) with Blacks (1 2.9%), other races 
(1 2.4%), and Hispanics (1 1.7%) following closely behind. Cataract is the main cause of low 
vision (excluding blindness) in Whites (59.2%), Blacks (50.9%), and Hispanics (46.7%) 
(EDPRG, 2004a). Cataract (36.8%) was the most common cause of blindness in Black 
Americans according to the EDPRG (2004a). 
As with ANID, the rates of cataract are better understood when data are summarized by 
age, gender, and race (See Table 2). In like manner, females have a higher rate of cataract 
compared with males of their race. Again, black females have a higher rate of cataract in the 
earlier years (age 40 to 69) while white females have a higher rate in the later years (age 70 to 3 
80). In contrast, compared to the sharp increase in advanced AMD with age among whites, the 
increase is gradual among both races and genders for cataract. 
Table 2 
Prevalence of cataract by age, gender and race 
Rate Der 100 individuals (95% CI) 
Gender/Age, years 
Females 
40-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75-79 
2 80 
Males 
40-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75-79 
White Race Black Race 
2 80 71.3 (67.0-75.2) 46.2 (37.9-54.6) 
Note. Adapted from EDPRG, 2004c. 
In summary, the incidence of AMD and cataract is expected to rise with higher rates 
among the Wisconsin population compared to the total U.S. Blindness from AMD and cataract 
can affect an individual's physical, social and psychological functioning as described above. 
Interestingly, an estimated 50% of all cases of blindness may be preventable (Prevent Blindness 
America, 2002). Dietary antioxidants are one possible route of prevention which will be 
discussed in the next section. Specifically, the role of lutein and zeaxanthin but also other 
carotenoids, vitamins A, C, and E, and zinc in the protection against ARED will be included. 
Dietary Intake, Serum Concentrations and Age-related Eye Disease 
The Eye Disease Case-Control Study (Seddon, Ajani, et al., 1994) evaluated the 
relationship between dietary intake of carotenoids and vitamins A, C, and E and the risk of late 
ANID in patients aged 55 to 80 years from five ophthalmology centers in the U.S. Total 
carotenoids, total vitamin A, beta-carotene, and lutein and zeaxanthin showed a significant trend 
of decreased risk with increasing intake. Lutein and zeaxanthin had the strongest association of 
the carotenoids and overall with a statistically significant trend (P <.001) for a reduced risk of 
late AMD. Spinach and collard greens were the only carotenoid-rich foods to show a significant 
inverse trend with late AMD. An 86% lower risk was found for those who ate five or more 
servings of spinach or collard greens (one serving equals 0.5 cups, cooked or raw) per week 
compared to those who ate less than one serving per month (OR: 0.14; 95% CI: 0.01, 1.2; P for 
trend = <.001). 
Two prospective studies compared carotenoid and vitamin A intake with the risk of 
cataract extraction in men and women. The intake of U.S. male health professionals aged 45 to 
75 years from the Health Professionals Follow-Up Study (Brown et al., 1999) and registered 
female nurses aged 45 to 71 years from the Nurses' Health Study (Chasm-Taber et al., 1999) 
were evaluated with a semi-quantitative food-frequency questionnaire. In the men, only lutein 
and zeaxanthin had a significant trend (P = .03) for decreased risk with increasing intake (Brown 
et al.). Men in the highest quintile of lutein and zeaxanthin intake (6.9 mg) had a 19% lower risk 
of cataract extraction compared to men in the lowest quintile (1.3 mg) (RR: 0.81; 95% CI: 0.65, 
1.0 1 ; P for trend = -03). In the women, both lutein and zeaxanthin and vitamin A without 
supplements showed a significant trend (P = .04) for decreased risk with increasing intake 
although only women at the top decile of lutein and zeaxanthin intake (13.7 mg) had a 
significantly decreased risk compared to the bottom quintile (1.2 mg) (RR: 0.78; 95% CI: 0.63, 
0.95; P for trend = .04) (Chasm-Taber et al.). Frequent intake (2 2 times per week) of cooked 
spinach was most strongly associated with lower risk with 3 8% lower risk than those with intake 
less than 1 time per month (RR: 0.62; 95% CI: 0.45, 0.86; P for trend = .005). 
Dietary intake and serum concentrations and AMD have been examined using data from 
the National Health and Nutrition Examination Survey (NHANES). Goldberg, Flowerdew, 
Smith, Brody, and Tso (1988) compared the consumption of vitamins A and C and the 
prevalence of AMD among persons aged 45 to 74 years from the NHANES I. Consumption data 
was collected through a 24-hour recall and food frequency questionnaire of fruits and vegetables 
rich in vitamins A and C reported as weekly intake over the previous three months. Intake of 
h i t s  and vegetables rich in vitamin A (OR: 0.57; 95% CI: 0.34,0.96) and rich in vitamin C 
(OR: 0.48; 95% CI: 0.27,0.87) four to six times per week from the food frequency data showed 
significance for a decreased risk of AMD. After adjustment for demographic and medical 
factors, only intake of h i t s  and vegetables rich in vitamin A seven or more times per week 
remained significant (OR: 0.59; 95% CI: 0.37,0.99). 
Mares-Perlman et al. (2001) compared the relationship between lutein and zeaxanthin in 
the diet and serum and photographic evidence of early and late AMD in persons aged 40 years 
and older from the NHANES 111. Intake data was obtained from a 60-item food frequency 
questionnaire. A significantly reduced risk of pigmentary abnormalities (early AMD) was found 
in persons aged 40 to 59 years from all races combined (OR: 0.1 ; 95% CI: 0.1,0.3) and Non- 
Hispanic Whites (OR: 0.3; 95% CI: 0.1,0.3) in those with the highest versus the lowest quintile 
of lutein and zeaxanthin intake in the diet. A significant reduction in late AMD was found in 
persons aged 60 to 79 years from all races combined in those with the highest versus the lowest 
quintile of lutein and zeaxanthin intake in the diet (OR: 0.1 ; 95% CI: 0.0,0.9). The 90th 
percentile for lutein and zeaxanthin intake was 5.6 mg in persons aged 40 to 59 years and 6.0 mg 
in persons aged 60 to 79 years. 
The relationship between serum carotenoids and tocopherols and AMD or cataract was 
compared using data from the Beaver Dam Eye Study, a case-control study within a population- 
based cohort. Mares-Perlman et al. (1 995) investigated the relationship between serum levels and 
AMD. No significant differences were found between mean levels of all carotenoids and 
tocopherols in persons with or without AMD. While a significantly lower mean level of alpha- 
tocopherol was found in persons with AMD than in persons without AMD (P = .03), the 
difference was no longer significant after adjusting for serum cholesterol levels. No significant 
differences were observed between the highest and lowest quintile of serum carotenoids and 
tocopherols and Ah4D. A significantly increased risk was shown in persons in the lowest quintile 
of serum lycopene versus all other quintiles combined before (OR: 1.9; 95% CI: 1 .O, 3.7) and 
after adjustment (OR: 2.2; 95% CI: 1 . l ,  4.5). Lyle et al. (1999) investigated the relationship 
between serum levels and cataract. There was a significant trend of decreased risk of cataract 
with increasing levels of serum tocopherol. Persons in the highest versus the lowest tertile of 
serum tocopherols showed a significantly reduced risk for cataract (OR: 0.4; 95% CI: 0.2,0.9; P 
= .03 for trend). 
Antioxidant Supplements and Intake and Age-Related Cataract 
The effect of antioxidant supplements on the prevention of age-related cataract has been 
studied. Robertson, Donner, and Trevithick (1 991) obtained the self-reported intake of vitamin 
supplements from the interviews of 304 persons (152 case-control pairs: 59 male, 93 female) 
living in southwestern Ontario. The majority (90%) of these participants were aged 60 years or 
older. Supplementary vitamin C (OR: 0.30; 95% CI: 0.12,0.75; P = .01) and E (OR: 0.44; 95% 
CI: 0.24,0.77; P = .004) intake among participants without cataract was significantly higher than 
that of the participants with cataract. These results suggest that supplementary vitamins C and E 
may reduce the risk of cataract by 70% and 56%, respectively. 
Jacques et al. (1 997) invited cataract-free women with the highest and lowest intakes of 
vitamin C from the Nurses' Health Study to participate in an investigation of supplement use 
over 10 to 12 years before assessment for lens opacities. There were 247 participants aged 56 to 
71 years (mean age at eye exam of 62.6 years). Most of the opacities found were early nuclear 
(61.1%). Women who took vitamin C supplements for 10 years or longer had a significantly 
lower risk of both early (OR: 0.23; 95% CI: 0.09, 0.60) and moderate (OR: 0.17; 95% CI: 0.03, 
0.87) opacities at any lens location. No evidence was found for reduced risk from vitamin C 
supplement intake for less than 10 years. 
Taylor et al. (2002) assessed the total nutrient intake from both food and supplements 
among women of the Nurses' Health Study and compared it with age-related cortical and 
posterior subcapsular (PSC) opacities from subsequent eye exams. Data were collected from 
questionnaires of 492 women aged 53 to 73 years over 13 to 15 years before eye assessment. 
Although no significant trends were found between any of the nutrients and either type of 
opacities in the overall cohort, a significant association was shown between age and total vitamin 
C intake and age and years of vitamin C intake for cortical opacities. A significant inverse trend 
was found only among those aged less than 60 years (P for trend .02) for cortical opacities with 
increasing vitamin C intake. Those in the highest quintile of vitamin C intake (OR: 0.43; 95% 
CI: 0.20,0.93) (364 mg to 2342 mg) had a 57% decreased risk for cortical lens opacities 
compared to those in the lowest quintile (140 mg or less). Similarly, a significant inverse trend 
was found only among those aged less than 60 years (P for trend .008) for cortical opacities with 
increasing duration of vitamin C supplement use. Those who took vitamin C supplements for 10 
years or longer (OR: 0.40; 95% CI: 0.18, 0.87) had a 60% decreased risk for cortical lens 
opacities compared to those who did not use vitamin C supplements. 
The use of vitamin supplements and risk for cataract has been studied among males. 
Seddon, Christen, et al. (1 994) examined the self-reported intakes of multivitamin, vitamin C, 
and/or vitamin E supplements in 17,744 cataract-free males aged 40 to 84 years from the 
Physicians' Health Study (PHs). Cataract was assessed by report of the participant in a follow- 
up questionnaire and documentation by ophthalmologist in the medical record. The authors did 
not find any significant association between use of vitamins C or E and reduced risk of cataract 
although these numbers were too small to evaluate. A marginally significant decreased risk of 
cataract was found among men who took only a multivitamin supplement (RR: 0.73; 95% CI: 
0.54, 0.99; P = .04) compared to men who did not take any vitamin supplements. In addition, a 
trend that approached significance (P for trend .06) was found for decreased risk of cataract with 
increasing duration of multivitamin use. 
Macular Pigment Density 
The macula lutea (macula), or yellow spot, of the retina contains the carotenoids lutein 
and zeaxanthin (Pratt, 1999). The central-most part of the macula, or the fovea, has the highest 
concentration of these yellow pigments (Snodderly, 1995). They are referred to as the macular 
pigment (Pratt). Two possible roles of the macular pigment have been suggested: filtering of 
damaging blue light from the sun and protection from oxidative damage to lipid membranes of 
the eye (Pratt). Low macular pigment density (MPD) may be a risk factor for AMD, cataract and 
age-related vision loss. Understanding the factors that influence MPD may assist in the 
prevention and treatment of these age-related eye diseases. 
MPD and visual sensitivity were assessed and compared between a group of younger 
participants (aged 24 to 36 years) and older participants (aged 60 to 84 years) who were non- 
smokers and had good ocular health (Hammond, Wooten, & Snodderly, 1998). The older age 
group showed a significant positive relationship between MPD and all three measures of visual 
sensitivity although no significant relationships were found in the younger subjects. When the 
age groups were combined and divided according to their MPD, the group with low MPD had 
significantly lower visual sensitivity (in one measure) than those with high MPD. A significant 
decrease in MPD was found only in persons older than 60 years. These results suggest that NIPD 
may prevent age-related loss of visual function. 
Studies have investigated the association of serum concentrations, adipose tissue 
concentrations, and dietary intake with MPD. A Netherlands study (Broekrnans et al., 2002) 
compared the association between serum lutein and zeaxanthin concentrations and adipose lutein 
concentrations on MPD in volunteers aged 18 to 75 years. This study found gender-related 
differences, which may explain the higher occurrence of AMD among women. Although serum 
lutein and zeaxanthin concentrations (P < .05) and adipose lutein concentrations (P < .001) were 
significantly lower in men than in women, mean MPD was 13% higher in men than in women (P 
= .02). An Indianapolis area study (Curran-Celentano et al., 2001) evaluated the serum 
concentrations, dietary intake, and MPD in volunteers between ages 18 and 50 years. Dietary 
intake was assessed using a one-year food frequency questionnaire. The study found a significant 
negative relationship between number of cigarettes smoked per day for current smokers and total 
serum carotenoids (r = -.32, P < .005) and serum lutein and zeaxanthin (r = -.26, P < .025). A 
significant positive relationship was found between serum lutein (r = .26, P < .0001), serum 
zeaxanthin (r = .20, P < .0001), and dietary intake of lutein and zeaxanthin (r = .21, P < .0005) 
and MPD. 
The relationship of anthropometric measurements to MPD has been investigated 
(Hammond, Ciulla, & Snodderly, 2002). Researchers tested the relationship between percent 
body fat and body mass index (BMI) and MPD in participants from Athens, Georgia and 
Indianapolis (mean age 29.6 years). The average BMI of participants from Athens and 
Indianapolis was 24 and 26, respectively. Percent body fat was assessed by bioelectric 
impedance and dietary intake was measured using a food frequency questionnaire. A significant 
inverse relationship was found between both BMI (r = -. 12, P < .0008) and percent body fat (r = 
-. 12, P < .0 1) and MPD although this relationship was influenced by participants with a high 
BMI and percent body fat. No relationship was found when these participants were removed. 
Mean MPD was significantly lower in participants with a BMI greater than 29 than those with a 
BMI less than 29. Similarly, mean MPD was significantly lower in participants with greater than 
27% body fat than those less than 27% body fat. In addition, dietary intake of lutein and 
zeaxanthin and total serum carotenoids were significantly lower in high BMI participants (>29). 
The authors hypothesized that these differences in MPD may be due to diet and competition with 
adipose tissue for lutein and zeaxanthin uptake. 
Scientists have attempted to manipulate macular pigment and tissue concentrations 
through diet. Hammond, Johnson, et al. (1997) tried to increase MPD through dietary intake of 
food sources of lutein and zeaxanthin. Thirteen non-smokers aged 30 to 65 years ate 60 grams of 
spinach and 150 grams of corn per day (n = 1 O), or ate only the spinach (n = 1) or the corn (n = 
2), with a meal andlor fat source in addition to their usual dietary intake for 15 weeks. Those 
who responded to the spinach and corn or spinach only (n = 8) had significant increases in MPD 
from baseline at weeks 4, 12, and 14 but had a temporary return to baseline at week 8. This is 
suggested to reflect interaction with other tissues (i.e. adipose). The responses to corn only 
differed with one person showing a considerable increase in serum zeaxanthin (70%) and MPD 
(25%) while the other person showed mild increases (6%, 7%) in these measurements, 
respectively. Johnson et al. (2000) followed the same dietary protocol of spinach and corn for 15 
weeks but also compared the relationships between anthropometric measurements, MPD, and 
serum, tissue, and dietary lutein concentrations. Similar to the results of Hammond, Johnson, et 
al. (1997), this study found a significant increase in MPD except at week 8. Interestingly, when 
MPD decreased at week 8, adipose tissue concentrations increased significantly. These studies 
show a possible competition between the adipose and macular tissue for serum carotenoids. 
Scientists have investigated the influence of lutein supplementation on MPD. Landrum et 
al. (1 997) provided 30 mg of free lutein per day to two healthy male volunteers (aged 42 and 5 1) 
for 140 days. The supplement, which was taken after breakfast, was natural lutein esters 
extracted from marigolds and suspended in 2 ml oil. An increase in MPD started at 
approximately days 20 to 40 and continued to increase 40 to 50 days after supplementation 
ended. Serum concentrations increased tenfold after 10 to 20 days of supplementation then 
dropped to baseline at about 60 days of discontinuing the supplement. The supplementation 
produced a 39% and 2 1 % mean increase in MPD in the two volunteers, respectively. Similarly, 
Berendschot et al. (2000) found a daily lutein supplement significantly increased MPD in eight 
nonsmoking volunteers albeit for a shorter length of time (12 weeks) and with a lower dose (10 
g). Landrum et al. showed little or no decrease in MPD after the serum concentrations returned to 
baseline, which may indicate a slow turnover rate in the retina. The authors suggest that MPD 
may reflect carotenoid consumption over an extended length of time. Consistent with this 
thought, Hammond, Johnson, et al. (1 997) found MPD to remain elevated for several months 
after ending a modified diet. 
Aging, Antioxidant Concentrations and Age-Related Cataract 
The lens is located behind the cornea and iris of the eye and is in contact with the 
aqueous humor (Taylor et al., 1995). The youngest tissue is composed of a unicellular layer of 
epithelial cells on the anterior surface. These cells divide, differentiate and are compressed 
posteriorly into the cortex. The oldest tissue is located in the nucleus of the lens (Yeum, Shang, 
Schalch, Russell, & Taylor, 1999). These three layers are surrounded by an outer collagenous 
membrane called the capsule (Taylor et al., 1995). The main role of the lens is to collect and 
focus light onto the retina. Cataract results when damage due to dehydration and photooxidation 
of the lens proteins causes opacification. 
The ocular lens is about 98% protein (Taylor et al., 1995). Since these lens cells are 
typically not lost with aging, they are at particular risk of harm from light and oxygen. This may 
come in the form of ultraviolet light and smoking as well as low concentrations of antioxidant 
nutrients. The lens protects itself fiom damage through antioxidant nutrients, antioxidant 
enzymes, and proteolytic enzymes. It has been proposed that cataract results from the imbalance 
of these protective systems as discussed elsewhere. 
Researchers have measured the concentration of antioxidant nutrients in the eye. Yeum, 
Taylor, Tang, and Russell (1 995) compared the carotenoid, retinoid, and tocopherol 
concentrations of normal and cataractous American and cataractous Indian lenses. Lutein and 
zeaxanthin were the only carotenoids while retinol, retinyl palmitate, alpha-tocopherol, and 
gamma-tocopherol were also found in the human lenses. No differences were found between the 
normal and cataractous American lenses. Interestingly, concentrations of lutein, zeaxanthin, and 
retinol were significantly higher in the Indian cataractous lenses than both the cataractous and 
normal Americans lenses. The authors suggest that other factors also determine cataract risk. 
Risk of a type of cataract may be related to the antioxidant concentrations in the layers of 
the lens. Yeum et al. (1999) compared the carotenoids, retinol, and tocopherol in the 
epithelium/cortex with those in the nucleus. The epithelium/cortex was found to have 3, 1.3, and 
1.8 times more lutein and zeaxanthin, retinol, and tocopherol, respectively. Of the total lens, 75% 
of lutein and zeaxanthin, 60% of retinol, and 64% of tocopherol were found in the 
epitheliudcortex. Even though less exposure to irradiation and oxygen occur in the nucleus, 
there is a greater occurrence of this type of cataract. Yeum et al. (1 999) have proposed that 
greater amounts of these antioxidants in the outer layers of the lens may explain the lower 
incidence of these types of cataract. 
Increased lens optical density (LOD) is an indicator of an aging lens with cataract being 
the end stage. Studies have shown a significant increase in LOD with age (Hammond, Wooten, 
& Snodderly, 1997; Berendschot et al., 2002). Hammond, Wooten, et al. (1997) compared the 
association between MPD and LOD in younger (aged 24 to 36 years) and older (aged 48 to 82 
years) subjects. A significant inverse relationship was found only in the older group (r = -.47, P 
< .001). Berendschot et al. (2002) confirmed these results (P = -.240, P = .005). These studies 
give support to lutein and zeaxanthin in the protection from age-related increases in LOD and 
cataract (Hammond, Wooten, et al., 1997; Berendschot et al., 2002). Since lutein and zeaxanthin 
can not be measured in the lens in vivo, MPD as a biomarker of lens health has shown to be 
effective. 
Major Clinical Trials 
The Age-Related Eye Disease Study (AREDS) was a double-blind, randomized, placebo- 
controlled clinical trial of 4600 participants in one of four categories of AMD selected from 11 
U.S. clinical centers (AREDS Group, 2001a). The AREDS evaluated the effect of high-dose 
vitamin C (500 mg), vitamin E (400 IU), beta-carotene (15 mg), zinc (80 mg) and copper (2 mg) 
supplements on AMD progression and visual acuity. Participants were randomly assigned to take 
daily tablets with: (1) antioxidants, (2) zinc and copper, (3) antioxidants plus zinc or (4) a 
placebo. Those not at risk for AMD received only the antioxidants to evaluate the risk of age- 
related cataract and visual acuity loss (AREDS Group, 2001b). Zinc (OR: 0.71; 99% C1: 0.52, 
0.99) and antioxidants plus zinc (OR: 0.66; 99% CI: 0.47,0.91) significantly reduced the risk of 
progression to advanced AMD in persons with intermediate and advanced AMD. But only those 
who received antioxidants plus zinc showed a statistically significant reduction in the rate of at 
least moderate visual acuity loss (OR: 0.73; 99% CI: 0.54,0.99). Alternatively, no effect of 
treatment on the development or progression of age-related cataract or visual acuity loss was 
found. The AREDS was the first National Institutes of Health funded study to determine the 
effect of high-dose dietary supplements on AMD. Notably, since commercial lutein supplements 
were not available at the start of the AREDS, this could not be evaluated (NEI, 2002, July). 
The Lutein Antioxidant Supplementation Trial (LAST) was a double-blind, randomized, 
placebo-controlled clinical trial of 90 patients with atrophic AMD at two Chicago area veterans 
medical facilities (Richer et al., 2004). The aim of the study was to evaluate the effect of lutein 
alone or lutein with carotenoids, antioxidants, vitamins and minerals on MPD and measures of 
central vision in persons with the most common form of AMD. In comparison, the LAST was 
shorter (1 year versus 7 years), had an older mean age (75 years versus 69 years), and had more 
male volunteers (95% versus 44%) than the AREDS (Richer et al.; AREDS Group, 2001a). 
Patients in the LAST were given: (Group 1) 10 mg lutein, (Group 2) 10 mg lutein combined with 
antioxidants, vitamins, and minerals (OcuPower@ fiom Nutraceutical Sciences Institute), or 
(Group 3) maltodextrin (Richer et al.). Contents of the OcuPower@ supplement given to Group 2 
are shown in Table 3. Visual function was assessed using several measures as described 
elsewhere. Of these measures, there was an objective improvement in MPD, Snellen visual 
acuity, and contrast sensitivity for Groups 1 and 2 while a subjective improvement in the Amsler 
grid for Group 1 and glare recovery in Group 2 was found. This is the first trial to show 
improvement of several visual functions in patients with AMD (North Chicago VA Medical 
Center, 2004). This study supports the effectiveness of lutein combined with antioxidants, 
vitamins and minerals in the treatment of AMD although further studies are needed to confirm 
this result. In addition, lutein supplementation was found to benefit all stages of AMD (Richer et 
al.) as opposed to the AREDS, in which high-dose vitamins and minerals were found to benefit 
only moderate to severe stages of AMD (AREDS Group, 2001a). 
Table 3 
Contents of the OcuPowerB supplement taken during the LAST study 
Ingredient Dose % RDNAI~ 
Lutein (FloraGloB) 10 mg -- 
Vitamin A 2500 IU 83- 108% 
Beta-carotene (BetateneB) 15000 IU -- 
Vitamin C (calcium ascorbate-Ester CB) 1500 mg 1667-2000% 
Vitamin D3 400 IU 67-200% 
Vitamin E (d-alpha tocopherol succinate) 500 IU 2222% 
Vitamin B 1 (thiamin) 50 mg 4167-4545% 
Vitamin B2 (riboflavin) 10 mg 769-909% 
Vitamin B3 (niacin) 70 mg 438-500% 
Vitamin B5 (pantothenic acid) 50 mg 1000% 
Vitamin B6 50 mg 2941-3846% 
Vitamin B 12 500 mcg 20833% 
Folic acid 800 mcg 200% 
Biotin 300 mcg 1000% 
Calcium 500 mg 42% 
Magnesium 300 mg 7 1 -94% 
Iodine 75 mcg 50% 
Zinc (L-methionine-L-OptiZincB) 25 mg 227-3 13% 
Copper 1 mg 10% 
Manganese 2 mg 87-1 11% 
Selenium 200 mcg 3 6% 
Chromium 200 mcg 667- 1000% 
Molybdenum 75 mcg 167% 
Lycopene 600 mcg -- 
Bilberry extract (25% anthocyanosides) 160 mg -- 
Alpha lipoic acid 150 mg -- 
N-acetyl cysteine 200 mg -- 
Quercetin 100 mg -- 
Rutin 100 mg -- 
Citrus bioflavonoids 250 mg -- 
Plant enzymes 50 mg -- 
Black pepper extract (BioperineB) 5 mg -- 
Malic acid 325 mg -- 
Taurine 900 mg -- 
L-glycine 100 mg -- 
L-glutathione 10 mg -- 
Boron 2 mg -- 
Note. See Richer et al., 2004. -- = No RDNAI 
aPercent Recommended Daily Allowance/Adequate Intake for females and 
males aged 50 years and over. 
Lutein and Zeaxanthin: Sources, Bioavailability and Metabolism 
Lutein and zeaxanthin can be obtained through foods or supplements. Dark green leafy 
vegetables such as kale, collard greens or spinach are the highest dietary sources of lutein and 
zeaxanthin while moderate amounts are found in green or yellow vegetables including squash, 
peas, broccoli, Brussels sprouts and corn (USDA, n.d.). Lutein first became available to the 
supplement market in 1995 in the form of purified, crystalline lutein and zeaxanthin from 
marigold flowers (Kreuzer, n.d.). It is now found in hundreds of nutritional supplements (Lutein 
Information Bureau, 2006). 
Scientists have studied the bioavailability and metabolism of carotenoids from foods and 
supplements. Castenmiller, West, Linssen, Hof, and Voragen (1 999) studied the affect of 
different levels of processed spinach on the availability of p-carotene and lutein. The study 
included a control, carotenoid supplement, whole leaf spinach, minced spinach, liquefied spinach 
and liquefied spinach plus dietary fiber group. All groups were fed the same 1-week cycle diet 
over a 3-week period. The authors found that processing spinach did not affect the bioavailability 
of lutein. The relative bioavailability of lutein was found to be 52% from minced spinach 
(Castenmiller et al.) and 67% from a high-vegetable diet (Hof et al., 1999) of the bioavailability 
of a lutein supplement added to salad dressing. This shows a lutein supplement is better absorbed 
by the body than vegetable-borne lutein. 
Lutein may compete with other carotenoids for absorption. Tyssandier et al. (2002) found 
competition in chylomicron response to vegetable-borne lutein and lycopene but no effect on 
plasma concentration after 3-week supplementation periods. There was a significant increase in 
plasma lutein concentrations after 3-week supplementation with chopped spinach, chopped 
spinach plus tomato puree, chopped spinach plus lycopene, and lutein plus tomato puree. Burri, 
Neidlinger, and Clifford (2002) compared the half-lives of common carotenoids in healthy 
women fed a low-carotenoid diet. Lutein was found to have the longest half-life at 76 days while 
zeaxanthin had a half-life of 38 days. 
Dietary Recommendations and Intake 
National organizations have set recommended intakes for fruits and vegetables. One of 
the Healthy People 201 0 objectives is to eat at least three servings of vegetables daily with at 
least one-third being dark green or orange (FDA & NIH, 2000). Only 3% of the population met 
this recommendation in 1994- 1996. The Dietary Guidelines for Americans recommends eating a 
variety of fruits and vegetables daily and to chose from all five vegetable subgroups, including 
dark green, several times weekly (USDHHS, 2005). The national 5 A Day for Better Health 
Program was started in 199 1 as a partnership between the vegetable and fruit industry and the 
U.S. government with the goal to increase intake of vegetables and fruits to 5 servings per day 
and decrease the incidence of chronic diseases (NCI, 2001). 
Currently, no recommended level of lutein and zeaxanthin intake has been proposed (The 
National Academy of Sciences, 2000) although the Eye Disease Case Control Study and analysis 
of the Third National Health and Nutrition Examination Survey found 5.8 mg (Seddon, Ajani, et 
al., 1994) and 6 mg (Mares-Perlman et al., 2001) per day, respectively reduced the risk of AMD. 
Analysis of the Nurses' Health Study and Health Professionals Follow-Up Study showed 6 mg 
(Chasm-Taber et al., 1999) and 6.9 mg (Brown et al., 1999) per day, respectively reduced the 
need for cataract surgery. The LAST study demonstrated 10 mg lutein per day improved visual 
function in persons with atrophic AMD (Richer et al., 2004). 
Although several studies have shown a relationship between diets high in lutein and 
zeaxanthin and eye health, consumption remains low (CDC, 2006). The Behavioral Risk Factor 
Surveillance System telephone health survey found that in 2005, only 23.2% of adults 
nationwide and 22.2% of adults in Wisconsin consumed fruits and vegetables five or more times 
per day. The 50th percentile for lutein and zeaxanthin intake varies according to study 
population. The Beaver Dam Eye Study showed a 0.9 mg per day intake (Mares-Perlman et al., 
1995) while the Eye Disease Case Control Study found a 1.7 mg per day intake (Seddon, Ajani, 
et al., 1994). 
Safety and Use of Dietary Supplements 
The safety of taking lutein and other nutritional supplements for age-related cataract and 
macular degeneration has been questioned (Sperduto, Ferris, & Kurinjj, 1990; Mares-Perlman, 
1999). In 1990, Sperduto et al. advised caution in the recommendation of supplements for age- 
related macular degeneration and cataract due to unknown efficacy and undefined toxicity levels 
for many nutrients. In 1999, Mares-Perlman warned that enthusiastically recommending lutein 
supplements for cataract before a strong body of scientific evidence is established would damage 
the credibility of science in the public eye and may cause adverse outcomes as was the case with 
p-carotene and lung cancer. The National Eye Institute (NEI) released a statement in July 2002 
explaining that claims supporting the role of lutein supplements in decreasing the risk of AMD 
or cataract were still speculative. Richer, the LAST lead investigator, makes clear in a North 
Chicago VA Medical Center (2004) statement that studies are needed of increased population 
and length of time on the treatment of AMD with lutein and antioxidant supplements. On the 
other hand, a recent study conducted by The Lewin Group (2006) for the Dietary Supplement 
Education Alliance estimated a five-year $2.5 million net savings through avoiding dependency 
associated with risk of AMD by taking 6-10 mg of lutein with zeaxanthin daily. Clearly, 
researchers differ in their perceptions of the appropriateness of lutein, zeaxanthin, and 
antioxidants for eye health. 
Despite the lack of evidence regarding the long-term safety and efficacy of lutein in the 
prevention and treatment of AMD and cataract, it has become the most used herbal and other 
natural dietary supplement (Kelly et al., 2005). The main source of lutein supplementation was 
from a multivitamin product. The National Marketing Institute's survey (November 20,2003) 
found 61.2% of Americans were aware of lutein, 29.2% said it was important for their stores to 
carry foods and beverages enriched with lutein, and 77.1 % said they were concerned with 
preventing vision problems (as cited in Kemin Industries, Inc., 2006). The results of these 
surveys show the need for optometrists and other eye healthcare professionals to stay informed 
of the research on lutein and eye health and to provide credible recommendations and 
educational materials that consider the current body of evidence. 
Optometry and Nutrition Education 
Optometrists are uniquely positioned to promote the intake of a healthy diet including 
dark green vegetables for optimal eye health. They may also provide credible information to 
guide patients on the use of nutritional supplements. The American Optometric Association's 
Clinical Practice Guidelines advises optometrists that evidence is increasing to support 
nutritional supplementation for eye health but that further research is needed to define those 
therapies (AOA, 1999). Eating five or more servings of dark green leafy vegetables per week is 
suggested to reduce risk for AMD. Dietary supplementation with vitamins C and E, beta- 
carotene and selenium is recommended for nutrient-deficient or noncompliant adults although 
optometrists are advised to consult with the patient's primary care physician before 
recommending nutritional supplements. Referring a patient to a registered dietitian may assist 
concerned optometrists in determining current dietary intake, the appropriateness of nutritional 
supplementation, or nutrition education for eye health. 
Chapter 111: Methodology 
Introduction 
The purpose of this study was to describe how the confidence of licensed Wisconsin 
optometrists in the relationship between diets high in lutein and zeaxanthin and eye health 
influenced their clinical practice as measured by a self-administered survey. This chapter will 
review subject selection and description, instrumentation, data collection, data analysis and 
limitations. 
Subject Selection and Description 
A complete listing of 794 licensed Wisconsin optometrists was obtained from the 
Wisconsin Department of Regulations and Licensing. After assigning a three digit number to all 
optometrists excluding those who pre-tested the survey, a random sample of 300 optometrists 
was selected using a table of random digits. A letter of consent was mailed to the sample of 
optometrists requesting their participation in the study (Appendix A). The letter specified the 
objectives of the study, the subjects' rights as study participants, and that returning the survey 
indicated their agreement to participate. Since the study instrument was designed for currently 
practicing optometrists, the letter asked that only currently practicing optometrists participate. A 
pre-addressed, pre-paid envelope was included for return of the survey instrument. The surveys 
were not coded or marked with an identification number, and did not have any personal 
identifiers therefore the sample was anonymous. 
Instrumentation 
A 20-item original survey was developed after a thorough review of epidemiological, 
prospective, and clinical studies on lutein and zeaxanthin found in nutrition, eye, and medical 
journals. Two locally practicing optometrists and one other practicing optometrist agreed to pre- 
test the survey for errors and to improve the quality. Modifications in survey length and content 
were made based upon the pre-test. A copy of the survey is located in Appendix B. Since the role 
of lutein and zeaxanthin in eye health is still under investigation, it was the aim of this study to 
gather the opinions and recommendations of the most frequently sought providers of eye care, 
optometrists. The items in the survey were divided into four main sections. 
The first section addressed Wisconsin optometrists' awareness of lutein and zeaxanthin, 
sources of information on lutein and zeaxanthin, and perception of the adequacy of the 
information on lutein and zeaxanthin. The first item was a 5-point scale measuring the 
awareness of optometrists on the relationship between lutein and zeaxanthin and eye health. The 
next two items were concerning the sources of information on the relationship between lutein 
and zeaxanthin and eye health. The first of the two items asked respondents to mark all of their 
sources of information while the second asked respondents to rank their top three most preferred 
sources of information. The last item in this section asked whether the information on lutein and 
zeaxanthin was adequate to make recommendations to patients. 
The second section asked respondents to mark which of the following foods or 
supplements they recommended to patients: (1) foods rich in lutein and zeaxanthin, (2) a lutein 
or zeaxanthin supplement, (3) a vitamin A or beta-carotene supplement, (4) a vitamin C 
supplement, (5) a vitamin E supplement, (6)  a zinc supplement, or a (7) multi-vitaminlmineral 
supplement. Patients were divided into five categories: (1) patients not at risk of AMD or 
cataract, (2) patients at risk of AMD, (3) patients at risk of cataract, (4) patients diagnosed with 
AMD, and ( 5 )  patients diagnosed with cataract. A follow-up question was placed after the item 
addressing the recommendation of a vitamin A or beta-carotene supplement. Respondents who 
recommended a vitamin A or beta-carotene supplement were asked if they recommended it to 
patients who smoked. 
The third section referred to the educational or informational materials the optometrist 
distributed to patients. The first question asked if the optometrist distributed educational or 
informational materials to patients at hisher practice. If the optometrist distributed educational 
or informational materials, the next question was whether helshe had educational or 
informational materials on lutein and zeaxanthin. If the optometrist had educational or 
informational materials on lutein and zeaxanthin, the next item asked the respondent to mark all 
the places where educational or informational materials on lutein and zeaxanthin were obtained. 
If the optometrist did not distribute educational or informational materials to patients at hisher 
practice or did not have educational or informational materials on lutein and zeaxanthin, the 
respondent was asked to rank hisher top three reasons for not distributing educational or 
informational materials on lutein and zeaxanthin. The last question in this section used a 7-point 
scale to determine the importance to the optometrist of having educational or informational 
materials on lutein and zeaxanthin to give to patients. 
The fourth section of the survey included three demographic questions and a comment 
section. The first question asked for the gender of the optometrist. The next question asked the 
number of years the respondent had been practicing optometry (rounded to the closest year). The 
last question asked the age of the optometrist. The survey concluded by asking respondents to 
comment if they felt that there was something missing from the survey regarding the topic of 
lutein and zeaxanthin and eye health. 
Data Collection Procedures 
Permission from the Institutional Review Board of the University of Wisconsin-Stout 
was granted before data collection began. This research project was partially funded through an 
award from the University of Wisconsin-Stout Student Research Fund. The letter of consent and 
the 20-item survey was sent on May 19,2003 with a requested response date of June 2,2003. 
Postcards were sent on May 30,2003 to remind optometrists to complete and return the survey 
with the date extended to June 13,2003 (Appendix C). In addition, a reminder to return the 
survey was published in the June issue of the Wisconsin Optometric Association's monthly 
newsletter. 
Data Analysis 
This study was descriptive in design. The majority of survey items were nominal 
variables. The researcher coded the survey variables then entered and analyzed the data using 
The Statistical Program for Social Sciences (SPSS) version 1 1.5 for Windows. Data were 
analyzed for descriptive statistics including frequency, percentage, mode, median, range of 
scores, mean, and standard deviation. Cross-tabulations were calculated to describe the data 
more fblly. 
Limitations 
The present study was limited in the sample size, research population, and survey design. 
The sample selected to receive the mailed survey represented only 38% of the total population of 
licensed Wisconsin optometrists. The research sample was selected from the total population of 
licensed Wisconsin optometrists. Therefore, inferences from the results should not be applied to 
optometrists nation-wide or ophthalmologists, who also provide eye care to patients. Data were 
collected via an original survey instrument. Since this survey was designed for this study, there 
are no measures of validity or reliability. 
Chapter IV: Results 
Introduction 
The purpose of this study was to determine the perceptions, recommendations, and 
educational materials of licensed Wisconsin optometrists regarding the relationship between 
lutein and zeaxanthin and eye health. A 20-item survey was mailed to 300 randomly chosen 
licensed Wisconsin optometrists. This chapter will describe demographic information, item 
analysis, selected item response by gender, response analysis within items, and research 
objectives. 
Demographic Information 
A one-page survey was sent to 300 optometrists on May 19,2003, which was followed 
by a reminder postcard 1 1 days later. A total of 128 surveys were returned. Of those surveys, 127 
were completed and one survey was returned because the address had changed and forwarding 
time had expired. Similarly, two postcards were returned due to the same reason. Two 
optometrists who reported that they only received the postcard contacted the researcher by phone 
to request another survey, which was resent. Therefore, it is estimated that 297 optometrists 
received both the survey and reminder postcard. The response rate was 42.3%. This represented 
16.0% of the total population of licensed optometrists in Wisconsin at that time. 
The fourth section of the survey included three demographic items, which will be 
discussed here. The first item in this section (n = 127) asked "What is your gender?" Ninety-five 
(74.8%) of the participants were male and 3 1 (24.4%) were female. 
Table 4 presents the response to the question "How many years have you been practicing 
optometry?" Respondents were asked to round to the closest year. The number of years 
practicing optometry ranged from two years to 45 years. The mean and median number of years 
practicing optometry were 16.9 years and 17.0 years, respectively. There was a standard 
deviation of 9.6 years. The data were bimodal with 20 years and 23 years being tied (6.3%) as 
the most fiequently reported number of years practicing optometry. Five years and 11 years were 
tied (5.5%) as the second most fiequently reported number of years practicing optometry. 
Table 4 
How many years have you been practicing 
optometry? (round to closest year) (n = 
127) 
Years n YO 
45 to 49 1 0.8 
Note. Respondents wrote in their years 
practicing. Responses have been grouped. 
Table 5 presents the response to the question "What is your age?'The mean and median 
ages of the optometrists were 43.6 years and 43.5 years, respectively. There was a standard 
deviation of 9.1 years. Ages ranged from 28 years to 70 years. The most frequently reported age 
of the optometrists was 44 years (6.3%) with 37 years, 39 years, and 55 years tied for second 
Table 5 
What is your age? (n = 127) 
Years n YO 
Note. Respondents wrote in their ages 
in years. Responses have been grouped. 
Item Analysis 
This portion of the chapter will provide an analysis of the data from the first three 
sections of the survey which include information on lutein and zeaxanthin and eye health, 
nutritional recommendations to patients, and educational or informational materials distributed to 
patients. Data from the fourth section of the survey were described above except for a request for 
comments at the conclusion of the survey, which said 
We are interested in your perceptions of lutein and zeaxanthin and eye health. If you feel 
that there is something missing from this survey that should have been asked to practicing 
optometrists regarding the topic of lutein and zeaxanthin and eye health, please comment 
below. 
These comments are included in Appendix D. Statistics will be limited to frequencies and 
percentages as the data are nominal and ordinal. After each item is described, cross-tabulations 
between items will be utilized to provide more detail about responses within selected items. 
Information on Lutein and Zeaxanthin and Eye Health 
The first section of the survey included four items. Table 6 presents the results to the 
question "How informed do you feel about the relationship between lutein and zeaxanthin and 
eye health?" No (n = 0) optometrists were uniformed, 20 (1 5.7%) were somewhat informed, 53 
(4 1.7%) were moderately informed, 45 (35.4%) were very informed, and 7 (5.5%) were 
extremely informed. The majority (n = 98,77.2%) of optometrists were moderately to very 
informed about the relationship between lutein and zeaxanthin and eye health. 
Table 6 
How informed do you feel about the relationship 
between lutein and zeaxanthin and eye health? 
(check one) (n = 127) 
Res~onse n % 
Uninformed 0 0.0 
Somewhat informed 20 15.7 
Moderately informed 5 3 41.7 
Very informed 45 35.4 
Extremely Informed 7 5.5 
Table 7 shows the response to the question "Where have you obtained information on the 
relationship between lutein and zeaxanthin and eye health?" Respondents were asked to check all 
that applied. Optometrists obtained information from the following: 27 (2 1.3%) from the TV, 
newspaper, radio, 22 (17.3%) from the Internet, 55 (43.3%) from colleagues, 63 (49.6%) from 
pharmaceutical companies or representatives, 1 14 (89.8%) from studies published in professional 
journals, 102 (80.3%) from materials published by professional organizations or obtained at 
professional meetings, 30 (23.6%) from the National Eye Institute, 25 (19.7%) from non-profit 
organizations dedicated to preventing age-related eye disease, and 7 (5.5%) from other sources. 
These other sources were continuing education (n = 3,2.4%), a lecture (n = 2, 1.6%), the 
Physician's Desk Reference for Nutritional Supplements (n = 1,0.8%), and PubMed (n = 1, 
0.8%). The top three obtained sources of information on the relationship between lutein and 
zeaxanthin and eye health were: (1) studies published in professional journals, (2) materials 
published by professional organizations or obtained at professional meetings, and (3) 
pharmaceutical companies or representatives. 
Table 7 
Where have you obtained information on the relationship between lutein 
and zeaxanthin and eye health? (check all that apply) (n -- 127) 
Response n % 
TV, newspaper, radio 27 2 1.3 
Internet 
Colleagues 
Pharmaceutical companies or 
representatives 
Studies published in professional 114 
journals 
Materials published by professional 102 
organizations or obtained at 
professional meetings 
National Eye Institute (NEI) 30 
Non-profit organizations dedicated to 25 
preventing age-related eye disease 
Other 7 
Table 8 shows the results to "Using a scale of 1 to 3, please rank your top 3 most 
preferred sources of information on lutein and zeaxanthin and eye health." Eighty-three (65.4%) 
preferred studies published in professional journals, 24 (1 8.9%) preferred materials published by 
professional organizations or obtained at professional meetings, and 5 (3.9%) preferred .the 
National Eye Institute as their most preferred source of information on lutein and zeaxanthin and 
eye health. Sixty-three (49.6%) preferred materials published by professional organizations or 
obtained at professional meetings, 24 (18.9%) preferred studies in professional journals, and 9 
(7.1%) preferred the National Eye Institute as their second most preferred source of information 
on lutein and zeaxanthin and eye health. Thirty-two (25.2%) preferred pharmaceutical companies 
or representatives, 22 (17.3%) preferred colleagues, and 21 (16.5%) preferred the National Eye 
Institute as their third most preferred source of information on lutein and zeaxanthin and eye 
health. Continuing education (n = 4,3.1%) and an educational lecture or course (n = 1,0.8%) 
were preferred sources of information on lutein and zeaxanthin and eye health in the "other" 
category. The most fiequently preferred sources of information on lutein and zeaxanthin and eye 
health were: (1) studies published in professional journals (n = 1 13, 89.0%), (2) materials 
published by professional organizations or obtained at professional meetings (n = 107, 84.2%), 
and (3) pharmaceutical companies or representatives (n = 42,33.1%). It appears that optometrists 
have obtained information fiom their preferred sources. 
Table 8 
Using a scale of 1 to 3, please rank your top 3 most preferred sources of 
information on lutein and zeaxanthin and eye health. (n = 127) 
Res~onse Rank n % 
TV, newspaper, radio 
Internet 
Colleagues 
Pharmaceutical companies or 
representatives 
Studies published in professional 
journals 
Materials published by professional 
organizations or obtained at 
professional meetings 
National Eye Institute (NEI) 
Non-profit organizations dedicated 
to preventing age-related eye disease 
Other: Continuing education 
Other: Educational lecture or course 
The next item asked "Is the information on lutein and zeaxanthin and eye health adequate 
for you to make recommendations to patients?Ninety-nine (78.0%) indicated the information 
on lutein and zeaxanthin and eye health was adequate, 16 (12.6%) indicated the information was 
not adequate while 12 (9.4%) indicated they were not sure if the information was adequate for 
them to make recommendations to patients. 
Nutritional Recommendations to Patients 
The second section of the survey included eight items. For each of the eight items, 
respondents were given six options. These included "patients not at risk of AMD or cataract," 
"patients at risk of AMD," "patients at risk of cataract," "patients diagnosed with AMD," or 
"patients diagnosed with cataract." If the optometrist did not recommend the foods or 
supplement, an option was given that said "I have not recommended [the foods or supplement] to 
patients." Item number eight was an exception, which asked "If you recommend a vitamin A or 
beta-carotene supplement to patients, do you recommend it to patients who smoke?" summary 
of these data are shown in Table 9 by subgroup. 
Table 9 
Subgroup 
NAR RAMD RC DAMD DC 
n n n n n 
Response ("4 ("A) (%I ("4 ("A) 
Spinach 16 99 20 10 1 19 
(12.6) (78.0) (15.7) (79.5) (15.0) 
Lutein 7 96 10 103 13 
(5.5) (75.6) (7.9) (8 1.1)  ( 1  0.2) 
Vitamin A 1 1  72 15 8 5 18 
(8.7) (56.7) (1 1.8) (66.9) (14.2) 
Vitamin C 14 49 2 7 5 8 28 
( 1  1 .O) (38.6) (21.3) (45.7) (22.0) 
Vitamin E 16 57 18 66 17 
(12.6) (44.9) (14.2) (52.0) (13.4) 
Zinc 9 8 5 8 10 1 9 
(7.1) (66.9) (6.3) (79.5) (7.1) 
Multi-vitamin 40 100 44 100 42 
(3 1.5) (78.7) (34.6) (78.7) (33.1) 
Note. NAR = not at risk of AMD or cataract; RAMD = at risk of AMD; RC = at 
risk of cataract; DAMD = diagnosed with AMD; DC = diagnosed with cataract. 
The first item in this section said "I recommend spinach or other foods rich in lutein and 
zeaxanthin to." Table 10 presents the data as respondents who recommended the foods or 
supplements to any patients. One hundred-nine (85.8%) recommended and 18 (14.2%) had not 
recommended spinach or foods rich in lutein and zeaxanthin to patients. Most respondents 
recommended spinach or other foods rich in lutein and zeaxanthin to those at risk (n  = 99, 
78.0%) or those diagnosed (n  = 101,79.5%) with AMD. 
The next item said "I recommend a lutein or zeaxanthin supplement to." One hundred-ten 
(86.6%) recommended and 16 (12.6%) had not recommended a lutein or zeaxanthin supplement 
to patients. Most respondents recommended a lutein or zeaxanthin supplement to those at risk (n  
= 96, 75.6%) or those diagnosed (n  = 103,8 1.1 %) with AMD. 
The next item said "I recommend a vitamin A or beta-carotene supplement to." Ninety- 
five (74.8%) recommended and 32 (25.2%) had not recommended a vitamin A or beta-carotene 
supplement to patients. Most respondents recommended a vitamin A or beta-carotene 
supplement to those at risk ( n  = 72,56.7%) or those diagnosed (n = 85,66.9%) with AMD. 
The next item asked "If you recommend a vitamin A or beta-carotene supplement to 
patients, do you recommend it to patients who smoke?" Of those who recommended a vitamin A 
or beta-carotene supplement (n  = 95),25 (26.3%) recommended and 66 (69.5%) had not 
recommended a vitamin A or beta-carotene supplement to patients who smoke. 
The next item said "I recommend a vitamin C supplement to." Seventy-five (59.1%) 
recommended and 52 (40.9%) had not recommended a vitamin C supplement to patients. Less 
than half of respondents recommended a vitamin C supplement to those at risk (n  = 49,38.6%) 
or those diagnosed (n  = 58,45.7%) with AMD. 
The next item said "I recommend a vitamin E supplement to." Seventy-four (58.3%) 
recommended and 52 (40.9%) had not recommended a vitamin E supplement to patients. Less 
than half of respondents recommended a vitamin E supplement to those at risk of AMD (n  = 57, 
44.9%) while more than half recommended it to those diagnosed with AMD ( n  = 66,52.0%). 
The next item said "I recommend a zinc supplement to." One hundred-eight (85.0%) 
recommended and 19 ( 1  5%) had not recommended a zinc supplement to patients. Most 
respondents recommended a zinc supplement to those at risk (n  = 85,66.9%) or those diagnosed 
(n  = 101,79.5%) with AMD. 
The last item said "I recommend a multi-vitamidmineral supplement to." One hundred- 
sixteen (91.3%) recommended and 1 1 (8.7%) had not recommended a multi-vitaminlmineral 
supplement to patients. Most respondents recommended a multi-vitamidmineral supplement to 
those at risk (n = 100, 78.7%) or those diagnosed (n = 100, 78.7%) with AMD. A multi- 
vitamidmineral supplement was the most recommended foods or supplement to those not at risk 
of AMD or cataract. The most recommended foods or supplements were a multi-vitamidmineral 
supplement (n = 1 16,91.3%), a lutein or zeaxanthin supplement (n = 1 10, 86.6%), spinach or 
foods rich in lutein or zeaxanthin (n = 109, 85.8%), and a zinc supplement (n = 108, 85%). 
Table 10 
I recommend [foods or supplements] to [any] patients (n = 
127) 
Response n 'YO 
Spinach or other foods 
Yes 109 85.8 
No 18 14.2 
Lutein or zeaxanthin 
Yes 110 86.6 
No 16 12.6 
Vitamin A or beta-carotene 
Yes 
No 
Vitamin C 
Yes 
No 
Vitamin E 
Yes 
No 
Zinc 
Yes 
No 
Multi-vitamidmineral 
Yes 116 91.3 
No 1 1  8.7 
Educational or Informational Materials Distributed to Patients 
The third section of the survey included five items. The first item in this section asked 
"Do you currently distribute educational or informational materials to patients at your practice?" 
One hundred-one (79.5%) currently distributed and 25 (19.7%) did not currently distribute 
educational or informational materials to patients at their practice in MayIJune of 2003. 
The next item asked "Do you have educational or informational materials on lutein and 
zeaxanthin?" Of those who were distributing educational or informational materials (n = 10 l), 5 1 
(50.5%) had educational or informational materials and 50 (49.5%) did not have educational or 
informational materials on lutein and zeaxanthin. 
Table 11 presents the results to the question "Where have you obtained your educational 
or informational materials on lutein and zeaxanthin?" Optometrists obtained materials from the 
following: 26 (5 1.0%) from the American Optometric Association, 18 (35.3%) from the National 
Eye Institute, 10 (19.6%) from the American Academy of Ophthalmology, 12 (23.5%) from the 
American Macular Degeneration Foundation, 7 (1 3.7%) from the Alliance for Aging Research, 
24 (47.1%) from pharmaceutical companies, 12 (23.5%) developed their own, and 1 1 (21.6%) 
from other sources. These other sources were 1 (2.0%) from an ophthalmology newsletter, 1 
(2.0%) from an article by an M.D., 3 (5.9%) from a Journal, 1 (2.0%) from commercially 
available patient pamphlets, 1 (2.0%) from another optometrist, 1 (2.0%) from Research to 
Prevent Blindness, 1 (2.0%) from PubMed, 1 (2.0%) from the American Academy of Optometry, 
and 1 (2.0%) from an ophthalmology group. The most frequently obtained sources of educational 
or informational materials on lutein and zeaxanthin were (I) the American Optometric 
Association, (2) pharmaceutical companies, and (3) the National Eye Institute. 
Table 11 
Where have you obtained your educational or informational 
materials on lutein and zeaxanthin? (check all that apply) (n = 
51) 
Response n YO 
American Optometric Association 26 51.0 
National Eye Institute (NEI) 18 35.3 
American Academy of 10 19.6 
Ophthalmology 
American Macular Degeneration 12 23.5 
Foundation 
Alliance for Aging Research 7 13.7 
Pharmaceutical companies 24 47.1 
I develop my own 12 23.5 
Other 11 21.6 
Table 12 shows the results to "If you currently do not distribute educational or 
informational materials on lutein and zeaxanthin, using a scale of 1 to 3, please rank your top 3 
reasons for not distributing educational or informational materials on lutein and zeaxanthin." 
Thirty-one (41.3%) marked "unsure of where to obtain," 18 (24.0%) marked "I would rather 
answer questions directly," and 17 (22.7%) marked "research is limited" as their most important 
reason for not distributing educational or informational materials on lutein and zeaxanthin. 
Twelve marked "time to obtain, develop, or reproduce" (1 6.4%), 12 marked "I would rather 
answer questions directly" (16.0%), and 10 (13.3%) marked "research is limited as the second 
most important reason for not distributing educational or information materials on lutein and 
zeaxanthin. Ten (1 3.7%) marked "time to obtain, develop, or reproduce," 9 (12.2%) marked 
"cost to obtain, develop, or reproduce," and 7 each marked "unsure of where to obtain" (9.3%) 
and "research is limited" (9.3%) as the third most important reason for not distributing 
educational or informational materials on lutein and zeaxanthin. The most frequent reasons for 
not distributing educational or informational materials on lutein and zeaxanthin were: (1) "unsure 
of where to obtain" (n = 43, 57.3%), (2) "I would rather answer questions directly" (n = 35, 
46.7%), (3) "research is limited" (n = 34,45.3%), and (4) "time to obtain, develop, or reproduce" 
(n = 27,37.0%). One respondent (1.3%) each specified the following four "other" reasons for not 
distributing educational or informational materials on lutein and zeaxanthin: an unspecified other 
reason, "lutein and zeaxanthin is included with other topic in my handout," "would like to have 
samples," and "misinformation is being passed around.. ." It should be noted that several 
respondents who had materials on lutein and zeaxanthin responded to this item. These responses 
were included in this item's total because these respondents may not be distributing the materials 
on lutein and zeaxanthin to patients. 
Table 12 
If you currently do not distribute educational or informational materials on lutein 
and zeaxanthin, using a scale of 1 to 3, please rank your top 3 reasons for not 
distributing educational or informational materials on lutein and zeaxanthin. 
Response Rank n 940 
Unsure of where to obtainC 1 3 1 41.3 
I would rather answer questions 
directlyC 
Not my responsibilityd 
No patient interestd 
Cost to obtain, develop, or reproduceb 
Time to obtain, develop, or reproducea 
Research is limitedC 
Available materials either have too 
small print or are above the reading 
level of my patientsd 
Other: unspecifiedb 
Other: Lutein and zeaxanthin is 
included with other topic in my 
handoutd 
Other: Would like to have samplesd 
Other: Misinformation is being passed 
aroundd 
Table 13 listed the results to "How important is it to you to have educational or 
informational materials on lutein and zeaxanthin to give to your patients?'The following 
responses were received: 14 (1 1.0%) marked extremely important, 32 (25.2%) marked very 
important, 50 (39.4%) marked somewhat important, 22 (17.3%) marked undecided, 4 (3.1%) 
marked somewhat unimportant, 3 (2.4%) marked very unimportant and no one marked extremely 
unimportant. It was somewhat to very important for the majority of optometrists (n = 82,64.6%) 
to have educational or informational materials on lutein and zeaxanthin to give to their patients. 
Table 13 
How important is it to you to have educational or 
informational materials on lutein and zeaxanthin to give 
to your patients? (n = 127) 
Response 
Extremely important 
Very important 3 2 25.2 
Somewhat important 5 0 39.4 
Undecided 22 17.3 
Somewhat unimportant 4 3.1 
Very unimportant 3 2.4 
Extremely unimportant 0 0.0 
Selected Item Response by Gender 
Gender of the optometrist was cross-tabulated with selected survey items to compare 
responses between genders. From a total of 124 respondents (94 male, 30 female), females felt 
slightly more informed than males about the relationship between lutein and zeaxanthin and eye 
health (Table 14). Eighty percent (n = 24) of females were moderately to very informed 
compared to 77.6% (n = 73) of males. Men (n = 17, 18.1 %) were more somewhat informed than 
women (n = 3, 10.0%) while women (n = 3, 10.0%) were more extremely informed than men (n 
Table 14 
How informed do you feel about the relationship between lutein and zeaxanthin and 
eye health? within gender (n = 124) 
Res~onse 
Gender Uninformed Somewhat Moderately Very Extremely 
Male 
n 0 17 3 8 3 5 4 
% within 0.0 18.1 40.4 37.2 4.3 
Female 
n 0 3 14 10 3 
% within 0.0 10.0 46.7 33.3 10.0 
From a total of 126 respondents (95 male, 3 1 female), a higher percentage of females (n = 
27, 87.1%) than males (n = 72, 75.8%) thought the information on lutein and zeaxanthin and eye 
health was adequate for them to make recommendations to patients (Table 15). Both genders 
were similar in the percentage of those who were not sure if the information was adequate 
(males: n = 9, 9.5%; females: n = 3,9.7%). 
Table 15 
Is the information on lutein and zeaxanthin and eye health 
adequate for you to make recommendations to patients? within 
gender (n = 1 26) 
Response 
Gender Yes No Not sure 
Male 
n 72 14 9 
% within 75.8 14.7 9.5 
Female 
n 27 1 3 
% within 87.1 3.2 9.7 
From a total of 125 to 126 respondents (53 to 85 male, 17 to 30 female), most of the 
supplements were recommended at a higher percentage by females than males (Table 16). 
Females recommended spinach or other foods rich in lutein and zeaxanthin (males: n = 8 1, 
85.3%; females: n = 28,90.3%), a vitamin A or beta-carotene supplement (males: n = 70,73.7%; 
females: n = 25, 80.6%), a vitamin C supplement (males: n = 53, 55.8%; females: n = 22, 
71.0%), and a multi-vitaminlmineral supplement (males: n = 85, 89.5%; females: n = 30,96.8%) 
at a higher percentage than males. Men recommended a vitamin E supplement (males: n = 57, 
60.6%; females: n = 17, 54.8%) and a zinc supplement (males: n = 83, 87.4%; females: n = 25, 
80.6%) at a higher percentage than females. Recommendation of a lutein or zeaxanthin 
supplement was similar between genders (males: n = 83, 88.3%; females: n = 27, 87.1 %). 
Table 16 
I recommend [foods or supplements] to patients within gender 
Response 
Vitamin Vitamin Vitamin Multi- 
Gender %inachb Luteina cb Ea zincb vitb 
Male 
n 8 1 8 3 70 53 5 7 83 85 
% within 85.3 88.3 73.7 55.8 60.6 87.4 89.5 
Female 
n 28 27 25 22 17 2 5 30 
% within 90.3 87.1 80.6 71 .O 54.8 80.6 96.8 
a n =  125. n =  126. 
In contrast to the gender results from the first three cross-tabulations, there is a larger 
difference in gender response when respondents were asked about having or the importance of 
having educational or informational materials to give to patients. From a total of 126 respondents 
(95 male, 3 1 female), a higher percentage of females (n = 30,96.8%) than males (n = 71,74.7%) 
currently distributed educational or informational materials to patients at their practice in 
MayIJune 2003 (Table 17). Of those that distributed educational or informational materials (n = 
101), a higher percentage of males (n = 42,59.2%) than females (n = 9,30.0%) had educational 
or informational materials on lutein and zeaxanthin (Table 18). 
Table 17 
Do you currently distribute educational or 
informational materials to patients at your 
practice? within gender (n = 126) 
Response 
Gender Yes No 
Male 
n 7 1 
% within 74.7 
Female 
n 3 0 
% within 96.8 
Table 18 
Do you have educational or informational 
materials on lutein and zeaxanthin? within 
gender (n = 101) 
Response 
Gender Yes No 
Male 
n 42 29 
% within 59.2 40.8 
Female 
n 9 2 1 
% within 30.0 70.0 
From a total of 125 respondents (94 male, 3 1 female), it was more important to females 
than males to have educational or informational materials on lutein and zeaxanthin to give to 
their patients (Table 19). It was somewhat to very important to 7 1 .O% (n = 22) of females 
compared to 63.8% (n = 60) of males. Only men thought it was unimportant to have educational 
or informational materials on lutein and zeaxanthin to give to their patients: somewhat to very 
unimportant to 7.4% (n = 7). 
Table 19 
How important is it to you to have educational or informational materials on lutein and 
V) 
Res~onse 
Important Unimportant 
Male 
n 10 26 3 4 17 4 3 0 
% within 10.6 27.7 36.2 18.1 4.3 3.2 0.0 
Female 
n 4 6 16 5 0 0 0 
% within 12.9 19.4 51.6 16.1 0.0 0.0 0.0 
Response Analysis within Items 
Where respondents obtained information on the relationship between lutein and 
zeaxanthin and eye health (item number two) was compared with how informed respondents felt 
about the relationship between lutein and zeaxanthin and eye health (item number one). The data 
are presented in Table 20. Those who obtained information from the internet had the highest 
percentage of extremely informed respondents (n = 5,22.7%) compared to those who obtained 
information elsewhere. Those who obtained information from the National Eye Institute had the 
highest percentage of very informed respondents (n = 15,5 1.7%) compared to those who 
obtained information elsewhere. Those who obtained information from colleagues had the 
highest percentage of moderately informed respondents (n = 25,46.3%) compared to those who 
obtained information elsewhere. And those who obtained information from the TV, newspaper, 
radio had the highest percentage of somewhat informed respondents (n = 6,23.1%) compared to 
those who obtained information elsewhere. None of these results include the "other" category 
due to limited response. 
Table 20 
How informed do you feel about the relationship between lutein and 
zeaxanthin and eye health? within Where have you obtained information 
on the relationshin between lutein and zeaxanthin and eve health? 
Response to Response to how informed 
obtained Uninformed Somewhat Moderately Very Extremely 
n 0 6 11 7 2 
% within 0.0 23.1 42.3 26.9 7.7 
Internet 
n 
% within 
Colleagues 
n 
% within 
Pharm 
n 
% within 
Studies 
n 
% within 
Materials 
n 
% within 
NEI 
n 
% within 
Non-profit 
n 
% within 
Lecture 
n 
% within 
CPE 
n 
% within 
PDR 
n 
% within 
PubMed 
n 
% within 
Note. TV = TV, newspaper, radio; Pharm = pharmaceutical companies or 
representatives; Studies = studies published in professional journals; 
Materials = materials published by professional organizations or obtained 
Table 20 Continued 
at professional meetings; NEI = National Eye Institute; Non-profit = non- 
profit organizations dedicated to preventing age-related eye disease; CPE 
= continuing education; PDR = physicians desk reference for nutritional 
supplements. 
The perceived adequacy of the information on lutein and zeaxanthin and eye health to 
make recommendations to patients (item number four) was compared with how informed 
respondents felt about the relationship between lutein and zeaxanthin and eye health (item 
number one). Results are found in Table 2 1. The majority of optometrists who thought the 
information was adequate to make recommendations to patients (n = 97) were moderately to very 
informed (n = 82, 84.5%) while the majority of those who thought the information was not 
adequate (n = 16) were somewhat to moderately informed (n = 15,93.7%). 
Table 2 1 
How informed do you feel about the relationship between lutein and 
zeaxanthin and eye health? within Is the information on lutein and 
zeaxanthin and eye health adequate for you to make recommendations to 
patients? (n = 125) 
Response to Response to how informed 
adequate Uninformed Somewhat Moderately Very Extremely 
Yes 
n 0 8 4 1 4 1 7 
% within 0.0 8.2 42.3 42.3 7.2 
No 
n 0 8 7 1 0 
% within 0.0 50.0 43.8 6.3 0.0 
Not sure 
n 0 4 5 3 0 
% within 0.0 33.3 41.7 25.0 0.0 
The recommendations of optometrists for spinach or other foods rich in lutein and 
zeaxanthin (item number five) and for a lutein or zeaxanthin supplement (item number six) were 
compared with the perceived adequacy of the information on lutein and zeaxanthin and eye 
health to make recommendations to patients (item number four). The results are shown in Tables 
22 and 23. Those who recommended spinach or other foods rich in lutein and zeaxanthin to 
patients (n = 109) were more likely (n = 88, 80.7%) to indicate the information on lutein and 
zeaxanthin and eye health was adequate to make recommendations compared to those who did 
not recommend spinach (n = 1 1 ,6  1.1 %). Those who did not recommend a lutein or zeaxanthin 
supplement were more likely to indicate the information on lutein and zeaxanthin and eye health 
was not adequate to make recommendations to patients (n = 10,62.5%) compared to those who 
did recommend a lutein or zeaxanthin supplement (n = 6, 5.5%). 
Table 22 
Is the information on lutein and zeaxanthin and eye health 
adequate for you to make recommendations to patients? 
within I recommend spinach or other foods rich in lutein 
and zeaxanthin to ~atients 
Response to Response to adequate 
recommend Not 
s~inach Yes No sure 
Yes 
n 8 8 9 12 
% within 80.7 8.3 11.0 
No 
n 11 7 0 
% within 61.1 38.9 0.0 
Table 23 
Is the information on lutein and zeaxanthin and eye health 
adequate for you to make recommendations to patients? 
within I recommend a lutein or zeaxanthin supplement to 
patients (n = 126) 
Response to Response to adequate 
recommend Not 
lutein Yes No sure 
Yes 
n 94 6 10 
% within 85.5 5.5 9.1 
No 
n 4 10 2 
% within 25.0 62.5 12.5 
Respondents who recommended foods or supplements to patients (item number five to 
12) was cross-tabulated with whether respondents recommended these foods or supplements to 
patients at risk or diagnosed with AMD (Table 24). Of those that recommend the foods or 
supplements in the survey, a majority recommended each of these to patients at risk or diagnosed 
with AMD. 
Table 24 
Patients at risk or diagnosed with AMD within I recommend [foods or 
supplements] to patients 
Response 
At Risk of Diagnosed with 
Response to AMD AMD 
recommend Yes No Yes No 
Spinacha 
n 
% within 
~ u t e i n ~  
n 
% within 
Vitamin AC 
n 
% within 
Vitamin cd 
n 
% within 
Vitamin Ee 
n 
% within 
zincf 
n 
% within 
Multi-vitaming 
n 
% within 
The recommendations of optometrists for spinach or other foods rich in lutein and 
zeaxanthin (item number five) and for a lutein or zeaxanthin supplement (item number six) was 
compared with whether optometrists had educational or informational materials on lutein and 
zeaxanthin (item number 14). Tables 25 and 26 present the results. A slightly higher percentage 
of optometrists who recommended spinach to patients (n = 90) had educational or informational 
materials on lutein and zeaxanthin (n = 46, 5 1.1 %) compared to those who did not recommend (n 
= 1 1) spinach or other foods rich in lutein and zeaxanthin to patients (n = 5,45.5%). On the other 
hand, optometrists who recommended a lutein or zeaxanthin supplement (n = 89) were 
noticeably more likely to have educational or informational materials on lutein and zeaxanthin (n 
= 48,53.9%) compared to those who do not recommend (n = 11) a lutein or zeaxanthin 
supplement to patients (n = 2, 18.2%). 
Table 25 
Do you have educational or informational 
materials on lutein and zeaxanthin? within I 
recommend spinach or other foods rich in lutein 
and zeaxanthin to patients (n = 10 1) 
Response to 
recommend Response to materials on lutein 
spinach Yes No 
Yes 
n 46 44 
% within 51.1 48.9 
No 
n 5 6 
% within 45.5 54.5 
Table 26 
Do you have educational or informational 
materials on lutein and zeaxanthin? within I 
recommend a lutein or zeaxanthin supplement to 
- - 
patients (n = 100) 
Response to 
recommend Response to materials on lutein 
lutein Yes No 
Yes 
n 48 4 1 
% within 53.9 46.1 
No 
n 2 9 
% within 18.2 8 1.8 
Perceived adequacy of the information on lutein and zeaxanthin and eye health to make 
recommendations to patients (item number four) was compared with whether optometrists had 
educational or informational materials on lutein and zeaxanthin (item number 14). Data are 
shown in Table 27. From a total of 101 respondents (83 yes, 9 no, 9 not sure), optometrists who 
thought the information was adequate were more likely (n = 46,55.4%) to have educational or 
informational materials on lutein and zeaxanthin than those who did not think the information 
was adequate (n = 1, 1 1.1 %). Those who were not sure if the information on lutein and 
zeaxanthin was adequate were slightly more likely to not have educational or informational 
materials on lutein and zeaxanthin (n = 5, 55.6%) than those who thought the information was 
adequate (n = 37,44.6%). 
Table 27 
Do you have educational or informational 
materials on lutein and zeaxanthin? within Is the 
information on lutein and zeaxanthin and eye 
health adequate for you to make 
recommendations to patients? (n = 101) 
Response to Response to materials 
adeauate Yes No 
Yes 
n 46 3 7 
% within 55.4 44.6 
No 
n 1 8 
% within 11.1 88.9 
Not sure 
n 4 5 
% within 44.4 55.6 
Whether optometrists had educational or informational materials on lutein and zeaxanthin 
(item number 14) was compared with the importance of having educational or informational 
materials on lutein and zeaxanthin (item number 17). See Table 28 for results. From a total of 
100 respondents (50 yes, 50 no), it was somewhat to extremely important to have educational or 
informational materials on lutein and zeaxanthin for the majority of optometrists who had 
materials on lutein and zeaxanthin (n = 48,96.0%) while it was undecided to very important to 
have materials on lutein and zeaxanthin for most of the optometrists who did not have materials 
on lutein and zeaxanthin (n = 47,94.0%). 
Table 28 
How important is it to you to have educational or informational materials on lutein and 
zeaxanthin to give to your patients? within Do you have educational or informational 
materials on lutein and zeaxanthin? (n = 100) 
Response to 
materials Response to how important 
on lutein Extremely Very Somewhat Undecided Somewhat Very 
Yes 
n 14 19 15 2 0 0 
% within 28.0 38.0 30.0 4.0 0.0 0.0 
No 
n 0 12 23 12 1 2 
% within 0.0 24.0 46.0 24.0 2.0 4.0 
Research Objectives 
Research Objective #1: Evaluate the awareness, sources of information, and confidence 
of Wisconsin optometrists on the relationship between diets high in lutein and zeaxanthin 
and eye health. 
The first section of the survey, which included item number one through four, addressed 
research objective #l .  The majority (n = 98, 77.2%) of optometrists were moderately to very 
informed about the relationship between lutein and zeaxanthin and eye health (Table 6). The top 
three obtained sources of information on the relationship between lutein and zeaxanthin and eye 
health were: (1) studies published in professional journals (n = 114, 89.8%), (2) materials 
published by professional organizations or obtained at professional meetings (n = 102, 80.3%), 
and (3) pharmaceutical companies or representatives (n = 63,49.6%) (Table 7). The most 
frequently preferred sources of information on lutein and zeaxanthin and eye health were: (1) 
studies published in professional journals (n = 113, 89.0%), (2) materials published by 
professional organizations or obtained at professional meetings (n = 107, 84.2%), and (3) 
pharmaceutical companies or representatives (n = 42, 33.1%) (Table 8). The majority of 
optometrists (n = 99, 78.0%) indicated the information on lutein and zeaxanthin and eye health 
was adequate for them to make recommendations to patients. 
Research Objective #2: Determine the nutritional recommendations of Wisconsin 
optometrists for the prevention or treatment of AMD and cataract. 
The second section of the survey, which included item number five through 12, focused 
on research objective #2. The following foods or supplements were recommended by 
optometrists in descending order: a multi-vitamidmineral supplement (n = 116,91.3%), a lutein 
or zeaxanthin supplement (n = 110, 86.6%), spinach or other foods rich in lutein and zeaxanthin 
(n = 109, 85.8%), a zinc supplement (n = 108, 85.0%), a vitamin A or beta-carotene supplement 
(n = 95,74.8%), a vitamin C supplement (n = 75,59.1%), and a vitamin E supplement (n = 74, 
58.3%) (Table 10). More than half of respondents recommended all foods or supplements in the 
survey except a vitamin C or vitamin E supplement to those at risk of AMD and except a vitamin 
C supplement to those diagnosed with AMD (Table 9). None of the foods or supplements in the 
survey were recommended by a majority of the optometrists to those not at risk of AMD or 
cataract, those at risk of cataract, or those diagnosed with cataract although about one-third of 
optometrists recommended a multi-vitamidmineral supplement to these groups. 
Research Objective #3: Assess the availability and importance of educational materials 
on lutein and zeaxanthin to Wisconsin optometrists. 
The third section of the survey, which included item number 13 through1 7, investigated 
research objective #3. Most optometrists were distributing educational or informational materials 
to patients at their practice (n = 101,79.5%) although about half (n = 51,50.5%) of those who 
were distributing materials had educational or informational materials on lutein and zeaxanthin. 
The most frequently obtained sources of educational or informational materials on lutein and 
zeaxanthin were (1) the American Optometric Association, (2) pharmaceutical companies, and 
(3) the National Eye Institute (Table 11). The most frequent reasons for not distributing 
educational or informational materials on lutein and zeaxanthin were: (1) "unsure of where to 
obtain" (n = 43, 57.3%), (2) "I would rather answer questions directly" (n = 35,46.7%), (3) 
"research is limited" (n = 34,45.3%), and (4) "time to obtain, develop, or reproduce" (n = 27, 
37.0%) (Table 12). It was somewhat to very important for the majority of optometrists (n = 82, 
64.6%) to have educational or informational materials on lutein and zeaxanthin to give to their 
patients (Table 13). 
Research Objective #4: Summarize the perceptions of Wisconsin optometrists of lutein 
and zeaxanthin and eye health. 
A request for comments located below item number 20 allowed respondents to write their 
perceptions of lutein and zeaxanthin and eye health or the survey itself (See Appendix D). A few 
respondents suggested questions they would ask other optometrists while many of the 
respondents explained why they recommend or do not recommend lutein and zeaxanthin 
supplements or made reference to the age-related eye disease study (AREDS). 
Research Objective #5: Describe the demographic characteristics of Wisconsin 
optometrists. 
The fourth section of the survey, which included item number 18 through 20, looked into 
research objective #5. Approximately three-fourths (74.8%) of the optometrists were men. The 
mean age of the optometrists was about 43 years (43.6 years). The youngest respondent was 28 
years while the oldest was 70 years. The mean number of years practicing optometry for the 
respondents was almost 17 years (1 6.9 years). The responding optometrists had been practicing 
from two to 45 years. 
Chapter V: Discussion 
Introduction 
The purpose of this study was to determine how the perceptions of licensed Wisconsin 
optometrists toward lutein and zeaxanthin and eye health affected their current practice. This 
section will include a discussion of the results, limitations, conclusions and recommendations for 
optometrists, patients and further study. 
Discussion 
Evidence is accumulating regarding the role of lutein and zeaxanthin in age-related eye 
disease (Mares-Perlman et al., 2002). Although the evidence is still preliminary as to support the 
use of spinach as a functional food for prevention and lutein and zeaxanthin supplements for the 
treatment of age-related eye disease, the consumption of spinach (Lucier, Allshouse, & Lin, 
2004) and the popularity of lutein supplements has risen (Kelly et al., 2005). As with any 
emerging therapy, it is important for health professionals to remain objective in their evaluation 
of potential treatments for disease and provide accurate, evidence-based advice to patients. 
This study investigated the sources of information licensed Wisconsin optometrists 
obtained on the relationship between lutein and zeaxanthin and eye health. Our results showed 
studies published in professional journals, materials published by professional organizations or 
obtained at professional meetings, pharmaceutical companies or representatives, colleagues, and 
the National Eye Institute to be the top five sources of information on the relationship between 
lutein and zeaxanthin and eye health. The National Eye Institute's National Eye Health 
Education Program (NEHEP) Low Vision Focus Groups Final Report found similar results (NEI, 
2004). Journal articles, continuing education classes, professional conferences, the internet, and 
conversations with colleagues were the most frequent responses to materials that 
ophthalmologists and optometrists use to educate themselves. 
The present study was not the first of its kind. After our study data were collected and 
analyzed, an internet search found a survey commissioned by Kemin Foods (Des Moines, Iowa), 
manufacturer of FloraGLOB brand lutein, that assessed the level of awareness, acceptance of 
and commitment to lutein in 150 randomly chosen ophthalmologists and 150 randomly chosen 
optometrists in the United States (Young Again Nutrients, 2002; HighBeam Research, Inc., 
2002). The study was conducted by Jefferson Davis Associates, an independent research firm in 
Cedar Rapids, Iowa, in June and July 200 1. 
Our study found about 86% of optometrists currently recommended spinach or other 
foods rich in lutein and zeaxanthin to their patients. This was slightly below the results of the 
Kemin Foods survey (Young Again Nutrients, 2002) in which 90% of ophthalmologists and 
optometrists believed consumers should eat foods naturally high in lutein such as spinach. Our 
study showed about 87% of optometrists recommended a lutein or zeaxanthin supplement to 
patients. Eighty-four percent of ophthalmologists and optometrists in the Kernin Foods survey 
(Young Again Nutrients) currently recommended lutein to their patients, which is slightly below 
our results. The most recommended nutritional supplement in our study was a multi- 
vitamidmineral supplement (91% of optometrists). This result supports the recommendation of 
Fletcher and Fairfield (2002) for all adults to take one multivitamin daily. In our study, of those 
that recommended a multi-vitamidmineral supplement, about 86% (86.2%) recommended it to 
those at risk or diagnosed with age-related macular degeneration (AMD). In contrast, while this 
survey did not ask if optometrists recommended a multi-vitamidmineral supplement with lutein, 
the Kemin Foods survey (Young Again Nutrients) found 86% of ophthalmologists and 
optometrists believed consumers who take a multivitamin should take one that includes lutein. It 
is unknown which subgroups the Kemin Foods respondents recommended a multivitamin with 
lutein for. 
We were interested in the educational or informational materials optometrists distributed 
to patients, particularly those on lutein and zeaxanthin. The most common sources of these 
materials were obtained from the American Optometric Association, pharmaceutical companies, 
the National Eye Institute, the American Macular Degeneration Foundation, and from 
developing their own. Although the NEHEP report (NEI, 2004) found more general sources, 
these sources appear to be consistent with our results. The most frequent materials NEHEP 
ophthalmologists and optometrists currently used to educate patients included journal articles, 
continuing education classes, pamphlets and brochures, videos, the internet, and professional 
conferences. 
Limitations 
This study was limited in the sample, population, and study design. First, the research 
sample was limited in size and by possible bias. The response rate was good although this 
represented only 16% of the total population of licensed Wisconsin optometrists. Optometrists 
who chose to respond to the survey may feel more strongly about the relationship between lutein 
and zeaxanthin and eye health than those who did not respond. Second, the study population was 
limited to the currently licensed optometrists in Wisconsin. Therefore, inferences from the results 
should only be applied to licensed Wisconsin optometrists rather than licensed optometrists in 
other states or nationwide or to ophthalmologists in Wisconsin, other states or nationwide. Third, 
data collection was via an original survey instrument. Since the survey was designed for this 
study, there are no measures of validity or reliability. At the time of data collection, the Age- 
Related Eye Disease Study (AREDS) was a major eye study in which optometrists were likely to 
base their nutritional recommendations. Our survey asked optometrists about their 
recommendations for these vitamins and minerals but each was asked separately. The most 
recommended supplement was a multi-vitamidmineral supplement. While the AREDS 
formulation was a multi-vitamidmineral supplement, it is not known what percentage of 
optometrists recommended this specific supplement to patients. 
Conclusions 
The objectives of this study were met. The first objective was to evaluate the awareness, 
sources of information, and confidence of Wisconsin optometrists on the relationship between 
diets high in lutein and zeaxanthin and eye health. The majority of respondents were moderately 
to very informed about the relationship between lutein and zeaxanthin and eye health (77.2%). 
Those who obtained information from the internet had the highest percentage of extremely 
informed respondents (22.7%) compared to those who obtained information elsewhere. The top 
three obtained sources of information on the relationship between lutein and zeaxanthin and eye 
health were also the top three most preferred sources of information on lutein and zeaxanthin and 
eye health. The majority of optometrists thought the information on lutein and zeaxanthin and 
eye health was adequate for them to make recommendations to patients (78.0%). This percentage 
was higher among female (87.1%) than male (75.8%) respondents. Most optometrists who 
thought the information was adequate were moderately to very informed (84.5%) while those 
who did not think the information was adequate were somewhat to moderately informed 
(93.7%). These results suggest that the more information optometrists obtained, the more likely 
they were to find that the information on lutein and zeaxanthin and eye health was adequate to 
make recommendations to patients. 
The second objective was to determine the nutritional recommendations of Wisconsin 
optometrists for the prevention or treatment of AMD and cataract. The majority of respondents 
recommended all foods or supplements listed in the survey except a vitamin C supplement to 
patients diagnosed with AMD and except a vitamin C or vitamin E supplement to patients at risk 
of AMD. When those who recommended each of the supplements was cross-tabulated with 
patients at risk or diagnosed with AMD, a majority of the respondents recommended all of these 
supplements to patients. None of the foods or supplements in the survey were recommended by a 
majority of the optometrists to patients at risk of cataract or patients diagnosed with cataract. It is 
concluded that most optometrists recommended a multi-vitamidmineral supplement to patients 
at risk or diagnosed with AMD although what formulations and for which stages of AMD are 
unknown. 
The third objective was to assess the availability and importance of educational materials 
on lutein and zeaxanthin to Wisconsin optometrists. The majority of optometrists were 
distributing educational or informational materials to patients at their practice (79.5%). Of the 
respondents who distributed these materials, about half had educational or informational 
materials on lutein and zeaxanthin (50.5%). Although a higher percentage of female (96.8%) 
respondents distributed educational or informational materials than males (74.7%), this was 
reversed for materials on lutein and zeaxanthin (males: 59.2%, females: 30.0%). Optometrists 
obtained their educational or informational materials on lutein and zeaxanthin from a variety of 
sources, the most common being the American Optometric Association (5 1.0%), pharmaceutical 
companies (47.1%), and the National Eye Institute (35.3%). Of those who did not distribute 
educational or informational materials on lutein and zeaxanthin, most respondents were unsure 
of where to obtain these materials (57.3%). It was somewhat to very important for the majority 
of optometrists (64.6%) to have educational or informational materials on lutein and zeaxanthin 
to give to their patients. This percentage was higher among females (71.0%) than males (63.8%). 
Twenty-eight percent of the optometrists who already had educational or informational materials 
on lutein and zeaxanthin thought it was extremely important to have educational or informational 
materials on lutein and zeaxanthin to give to patients compared to none of the optometrists who 
did not have educational or informational materials on lutein and zeaxanthin. This implies that 
optometrists will seek out patient materials on lutein and zeaxanthin if it is important to them. 
Recommendations 
While it is encouraging that none of the respondents in our study were uninformed about 
the relationship between lutein and zeaxanthin and eye health, a modest amount were only 
somewhat informed (15.7%). When results of the less informed (somewhat and moderately) and 
more informed (very and extremely) respondents were split between two groups, there was a 
majority of less informed (57.5%) compared to the more informed (40.9%) respondents. This 
supports the need for optometrists to become more informed of the current state of literature on 
lutein and zeaxanthin and eye health. Future research should focus on the reason optometrists 
were less informed so appropriate educational strategies can be developed. 
It was found that respondents who obtained information from the internet (22.7%), the 
National Eye Institute (20.7%), and non-profit organizations dedicated to preventing age-related 
eye disease had the highest percentage of respondents who were extremely informed. These 
results suggest that optometrists found these to be the most effective sources for obtaining 
information on the relationship between lutein and zeaxanthin and eye health. 
It was interesting to find differences in the availability and importance of educational or 
informational materials on lutein and zeaxanthin among male and female respondents. Although 
a higher percentage of women (96.8%) had educational or informational materials than men 
(74.7%), men (59.2%) had a higher percentage of educational or informational materials on 
lutein and zeaxanthin than women (30.0%). A higher percentage of women (83.9%) thought it 
was somewhat to extremely important to have educational or informational materials on lutein 
and zeaxanthin to give to patients compared to men (74.5%) while a higher percentage of men 
(7.4%) thought it was somewhat to very unimportant compared to women (0%). Gender was 
cross-tabulated with two options from item 16 that asked respondents to rank their top three 
reasons for not distributing materials on lutein and zeaxanthin (i.e. unsure of where to obtain, I 
would rather answer questions directly). It is intriguing to note that 30.9% of men (n = 17) while 
only 5.0% of women (n = 1) ranked "I would rather answer questions directly" as their most 
important reason for not distributing educational or informational materials on lutein and 
zeaxanthin. In addition, 57.9% of women (n = 11) and 35.7% of men (n = 20) ranked "unsure of 
where to obtain" as their most important reason for not distributing educational or informational 
materials on lutein and zeaxanthin. 
In summary, it appears that although a higher percentage of women had educational 
materials and thought it was more important to have these materials than men, a higher 
percentage of women did not know where to obtain these. On the other hand, it looks as if men 
were less likely to have educational or informational materials because it was less important to 
them (although had a higher percentage of materials on lutein and zeaxanthin) and they would 
rather instruct patients verbally. This shows a need for organizations to publicize the availability 
of educational or informational materials to optometrists as a majority of female optometrists 
were unsure of where to obtain these materials. Men may have had more materials on lutein and 
zeaxanthin because they knew where to obtain these. Optometrists may also find it helpful to 
stay connected to services of professional, governmental, and non-profit organizations to 
improve their current practice. In addition, patients may benefit from having an optometrist who 
provides information in a format conducive to their learning preference. 
In conclusion, this survey attempted to measure several aspects of how lutein and 
zeaxanthin affected the practice of licensed Wisconsin optometrists. Future research should focus 
on increasing sample size, including ophthalmologists and modifying the survey to include items 
that address barriers to obtaining information on nutrition for eye health, recommendations for 
specific formulations of nutritional supplements, and frequency of referrals to a dietitian. It 
would also be interesting to do a follow-up survey to compare responses from the original to at 
least five years post-study. 
As research accumulates on the influence of nutrition in the prevention of age-related eye 
disease, it is anticipated that there will be an increased demand from patients and insurers to 
provide nutrition education to improve patient outcomes. With the lack of financial incentive for 
optometrists to provide this type of education, patient educational materials or a referral to a 
dietitian may be key strategies in improving the ocular and overall health of the patient. 
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Appendix A: Cover Letter 
May 19,2003 
Dear Dr. 9 
I am a graduate student at the University of Wisconsin-Stout and am interested in the relationship 
between diets high in lutein and zeaxanthin and eye health including the prevention of age-related 
macular degeneration (AMD) and cataract. For my research study in Food and Nutritional Sciences, I 
have chosen to send a survey to optometrists in Wisconsin regarding this topic. The objectives of my 
research are: (1) to evaluate the awareness and sources of information of Wisconsin optometrists on the 
relationship between lutein and zeaxanthin and eye health; (2) to determine the nutritional 
recommendations of Wisconsin optometrists for age-related eye disease; and (3) to assess the availability 
of educational materials on lutein and zeaxanthin to Wisconsin optometrists. Enclosed is a simple, 20- 
question survey for you to fill out and return in the self-addressed stamped envelope by June 2, 2003. 
There are no personal identifying questions that will allow me as the researcher to connect your returned 
survey with you as an individual optometrist. Please note that this survey was designed for currently 
practicing optometrists. Therefore, if you are not currently practicing, please disregard our request. 
It is understood that by returning this survey, you are giving your informed consent as a participating 
volunteer in this study. The potential risks to you as a practicing optometrist participating in this study 
are minimal. The potential benefits that might be realized from the successful completion of this study 
are an increased knowledge of Wisconsin optometrists' sources of information on lutein and zeaxanthin, 
their nutritional recommendations for age-related eye disease, and their availability of educational 
materials on lutein and zeaxanthin. The information is being sought in a specific manner so that your 
anonymity is guaranteed. You have the right to refuse to participate by not returning the survey. 
Questions or concerns about the research study should be addressed to Tara Larson, the researcher, phone 
(507) 436-5448, or Janice Coker, the research advisor, phone (715) 232-2239. Questions about the rights 
of research subjects can be addressed to Sue Foxwell, Human Protections Administrator, UW-Stout 
Institutional Review Board for the Protection of Human Subjects in Research, 11 Harvey Hall, 
Menomonie, WI 5475 1, phone (71 5) 232-1 126. 
Your participation in this study is very important to us. Please know that we appreciate your time and are 
requesting your response by June 2,2003. 
Sincerely, 
Tara A. Larson 
Graduate Student 
Department of Food and Nutrition 
University of Wisconsin-Stout 
Appendix B: Survey Instrument 
Note: Original survey was one page, printed on both sides of 8.5 inch x 14 inch paper, and 
organized into four columns. 
Please return this survey by June 2,2003 in the pre-addressed postagepaid envelope provided. 
Thank you 
Department of Food and Nutrition 
c/o Tara Larson, graduate student 
University of Wisconsin-Stout 
Menomonie, WI 54751-0790 
Email: larsonta~uwstout.edu 
Several recent studies have indicated a relationship between diets high in lutein and zeaxanthin and eye 
health including the prevention of agerelated macular degeneration (AMD) and cataract. 
1. How informed do you feel about the relationship between lutein and zeaxanthin and eye health? (check 
one) 
Uninformed 
- Somewhat informed 
- Moderately informed 
- Very informed 
Extremely informed 
2. Where have you obtained information on the relationship between lutein and zeaxanthin and eye health? 
(check all that apply) 
lV, newspaper, radio 
lnternet 
Colleagues 
Pharmaceutical companies or representatives 
Studies published in professional journals 
Materials published by professional organizations or obtained at professional meetings 
National Eye Institute (NEI) 
Non-profit organizations dedicated to preventing agerelated eye disease 
Other (please specify) 
~p - - 
- 
I haven't obtained any information. 
3. Using a scale of 1 to 3, please RANK YOUR TOP 3 MOST PREFERRED SOURCES of information on lutein 
and zeaxanthin and eye health. 
lV, newspaper, radio 
- Internet 
- Colleagues 
Pharmaceutical companies or representatives 
Studies published in professional journals 
Materials published by professional organizations or obtained at professional meetings 
National Eye Institute (NEI) 
- Non-profit organizations dedicated to preventing agerelated eye disease 
Other (please specify) 
4. Is the information on lutein and zeaxanthin and eye health adequate for you to make recommendations 
to patients? (check one) 
- Yes 
No 
Not sure 
We are interested in your current nutritional recommendations to patients. Please check which patients you 
recommend the following foods or supplements to. (check all that apply) 
5. 1 recommend spinach or other foods rich in lutein and zeaxanthin to 
- 
Patients NOT at risk of AMD or cataract 
Patients at risk of AMD 
- 
Patients at risk of cataract 
Patients diagnosed with AMD 
- Patients diagnosed with cataract 
- 
I have not recommended spinach or other foods rich in lutein and zeaxanthin to patients. 
6. 1 recommend a lutein or zeaxanthin supplement to 
Patients NOT at risk of AMD or cataract 
- 
Patients at risk of AMD 
- Patients at risk of cataract 
Patients diagnosed with AMD 
- Patients diagnosed with cataract 
I have not recommended a lutein or zeaxanthin supplement to patients. 
7. 1 recommend a vitamin A or betacarotene supplement to 
Patients NOT at risk of AMD or cataract 
- 
Patients at risk of AMD 
- 
Patients at risk of cataract 
- Patients diagnosed with AMD 
- Patients diagnosed with cataract 
I have not recommended a vitamin A or betacarotene supplement to patients. 
8. If you recommend a vitamin A or betacarotene supplement to patients, do you recommend it to patients 
who smoke? 
Yes 
No 
9. 1 recommend a vitamin C supplement to 
Patients NOT at risk of AMD or cataract 
Patients at risk of AMD 
Patients at risk of cataract 
Patients diagnosed with AMD 
Patients diagnosed with cataract 
- I have not recommended a vitamin C supplement to patients. 
10. 1 recommend a vitamin E supplement to 
Patients NOT at risk of AMD or cataract 
- 
Patients at risk of AMD 
Patients at risk of cataract 
- Patients diagnosed with AMD 
- Patients diagnosed with cataract 
I have not recommended a vitamin E supplement to patients. 
11. I recommend a zinc supplement to 
Patients NOT at risk of AMD or cataract 
- 
Patients at risk of AMD 
- 
Patients at risk of cataract 
Patients diagnosed with AMD 
- Patients diagnosed with cataract 
I have not recommended a zinc supplement to patients. 
12. 1 recommend a multi-vitamin/mineraI supplement to 
- 
Patients NOT at risk of AMD or cataract 
Patients at risk of AMD 
Patients at risk of cataract 
Patients diagnosed with AMD 
Patients diagnosed with cataract 
- I have not recommended a multi-vitamin/mineraI supplement to patients. 
We are interested in the educational or informational materials you distribute to patients. 
13. Do you currently distribute educational or informational materials to patients at your practice? (check 
one) 
Yes 
No (skip next 2 questions) 
14. Do you have educational or informational materials ON LUTEIN AND ZEAXANTHIN? (check one) 
Yes 
No (skip next question) 
15. Where have you obtained your educational or informational materials ON LUTEIN AND ZEAXANTHIN? 
(check all that apply) 
American Optometric Association 
National Eye Institute (NEI) 
American Academy of Ophthalmology 
- American Macular Degeneration Foundation 
Alliance for Aging Research 
Pharmaceutical companies 
I develop my own 
Other (please specify) 
16. IF YOU CURRENTLY DO NOT DISTRIBUTE educational or informational materials ON LUTEIN AND 
ZEAXANTHIN, using a scale of 1 to 3, please RANK YOUR TOP 3 REASONS for NOT distributing 
educational or informational materials on lutein and zeaxanthin. 
- Unsure of where to obtain 
I would rather answer questions directly 
Not my responsibility 
- No patient interest 
- Cost to obtain, develop, or reproduce 
- Time to obtain, develop, or reproduce 
- Research is limited 
- Available materials either have too small print or are above the reading level of my patients 
Other (please specify) 
17. How important is it to you to have educational or informational materials ON LUTEIN AND ZEAXANTHIN 
to give to your patients? (check one) 
Extremely important 
- Very important 
Somewhat important 
- Undecided 
Somewhat unimportant 
- Very unimportant 
- Extremely unimportant 
We would like to ask you some demographic questions to better describe the optometrists in our study. 
18. What is your gendefl 
Male 
Female 
19. How many years have you been practicing optometry? (round to closest year) 
20. What is your age? 
We are interested in your perceptions of lutein and zeaxanthin and eye health. If you feel that there is 
something missing from this survey that should have been asked to practicing optometrists regarding the 
topic of lutein and zeaxanthin and eye health, please comment below. 
Thank you for your participation in our study. 
Appendix C: Reminder Postcard 
Dear optometrist, 
We would like to remind you to complete the survey on lutein and zeaxanthin and eye health we 
sent you by mail and return it in the postage-paid envelope provided. If you have already 
returned your completed survey, we would like to thank you for your participation. If you have 
not yet completed the survey, we have extended our requested date of return to June 13, 
2003. We hope this will allow you sufficient time to answer our simple 20-question survey. We 
look forward to receiving your answers. If you are not currently practicing optometry, please 
disregard our reminder. 
If you have any questions or concerns, please contact us at (507) 436-5448, Tara Larson, 
researcher, or (71 5) 232-2239, Janice Coker, research advisor. 
Appendix D: Comments from Respondents 
We are interested in your perceptions of lutein and zeaxanthin and eye health. If you feel that 
there is something missing from this survey that should have been asked to practicing 
optometrists regarding the topic of lutein and zeaxanthin and eye health, please comment below. 
Note: Comments were transcribed as closely to original as possible. Therefore, misspelled words 
were included. 
I feel it is better safe than sorry - if there is a chance of them working against ARM use 
them. 
I have read a lot regarding lutein but very little on zeaxanthin - would be interesting to know 
if others felt the same - I answered all questions based on my experience with lutein. - 
Perhaps you should separate the two. 
The main reason I don't recommend luteidzeaxanthin is that it was not included in the 
AREDS (Age Related Eye Disease Study) Study. As I obtain study results confirming the 
benefits of luteidzeaxanthin, I would be more willing to recommend it. 
I give information to my ARMD patients on the AREDS study and discuss the added 
probable benefit of lutein & zeaxanthidgreen leafy veg. I don't at this point have material 
that I distribute with the lutein & zeaxanthin info on it. 
How often do patients specifically ask about lutein & zeaxanthin (Pt interest) 
I think there is not enough scientific data to know for sure if these are helpful for AMD. They 
have not shown to 1 incidence of cataract. More research needs to be done. 
You should have asked about recommendations for the specific supplements used in the 
AREDS study, which DID show clear benefit to some people with AMD. 
Thank you for taking the time and your interest in this area of study. I eagerly await the 
results of your survey. 
Unfortunately the studies to determine the effectiveness of lutein & zeaxanthin are very small 
samples and not of long duration like the Age Related Eye Disease Study (AREDS) was to 
show effectiveness of antioxidants and zinclcopper supplements. Doseage amounts and other 
factors are only determined for now on very weak study results and mostly set by supplement 
manufacturers. Therefore to recommend a supplement to a patient for the carotenoids is only 
done on a "we think it may be beneficial" basis. Quoting PDR for Nutritional Supplements 
"...show some promise of protecting against macular degeneration and may reduce the risk 
of cataract in some. Not exactly the confidence level one needs to prescribe these 
supplements with the assurance you can alter the course of a disease. 
Ask the questions: what information should be lor would you like to see1 on the pamphlets 
given out to your patients. 
Not aware of double blind studies like ARED study of ocuvite. 
Do you see studies have shown a solid relationship between lutein & zeaxanthin and see 
progression (not development) of macular degeneration? 
Unless I'm mistaken, it sounds like this study is being paid for by a pharmaceutical company. 
I think it is important to stress (1) A good diet with Fresh fruits and vegetables. (2) Moderate 
exercise (3) No smoking. Although supplements are good they give a false impression. A 
healthy Lifestyle will do more in most cases than taking high dose supplements. 
I am not aware of any studies conducted on these, other than those funded by pharmaceutical 
companies. 
Good luck on your study. My good friend did much of the original research on this subject at 
the University of Houston. He's a univ of -- grad circa 197 1, career Army. Dr. 
Morris Lattimoie not sure of his result or where this info. may have been published. I saw 
parts in numerous journal studies in 1990's. 
I do not feel that the evidence for lutein and zeaxanthin, zinc, B-carotene, Vit E and Vit C are 
conclusive. The cause of age related macular degeneration of both the wet and dry forms are 
obscure and appear to have relationships to UV exposure, ethnicity (especially fair skin), 
nutrition, smoking and as yet unidentified factors. Having said this, a nutritional andor 
supplemental approaches are relatively inexpense, probably cause no harm and may be 
proven to help with macular degeneration. Therefore, I usually recommend the use of 
supplements, eg, Ocuvite, to those patients presenting with drusen, macular pigmentary 
changes and early dry age related macular degeneration There also comes a time, eg, 
geographic atrophy, when nutritional approaches are too late. 
As optometrists counsel patients on the use of supplements, they must also inform patients of 
the cost of such products as Ocuvite. A monthly supply is approximately $20 = $240/yr 
which is a large amount for low income seniors. High intake of green leafy vegetables might 
be there only option.. .which is an excellent option overall. 
1) Do you feel research has been convincing enough to state claims and specific regimens to 
a vulnerable subgroup of people yes, no, undecided (2) Do you feel research has been done 
and proven that you will not be doing peripheral damage to people in certain megadosing 
vitamin therapy. yes, no, undecided 
I don't understand the push for supplement with lutein and now there is a push for 
Preservision which doesn't contain Lutein. I don't understand why. I would like to have a 
copy of the results of your study. 
Basing current recommendations on National Eye Institute longitudinal study substantiating 
that approximately 25% of people with beginning macular degeneration can benefit from 
antioxidants and zinc supplements. 
There is too much confusion already amongst patients (especially the elderly) who are 
relying on info fiom different sources (MDs, ODs, RPhslTV, Radio, Newsprint, Advertising, 
word-of-mouth, etc) Even Ocuvite is in different formulations: The high dose AREDS 
formula vs a 100% USRDA & Lutein formulation. These people tend to believe almost 
anything they are told, but also most are on fixed incomes and cannot afford extensive & 
EXPEN$IVE supplements that just are not necessary! ! ! *Anyone concerned enough to ask, I 
recommend they take a regular multivitamin & eat their "green leafy veggies." The AREDS 
formula was of limited value & only to those with advanced AMD in one eye, but not the 
other yet, or moderate AMD - so those are the ones I recommend the higher dosing to - with 
important reservations [underlined three times]! Those who smoke (vs Quit Smoking!) or 
live with smokers + Zinc only - warnings on interactions of OTC meds, supplements, & 
Rx'd meds. - warnings on possibly depleting copper by taking high dose zinclas well as the 
vitamin Ameta C & Smoking risks. I also ALWAYS advise them to ALSO check with their 
regular physician in case he knows of any meds or complications that contraindicate these 
supplements that the patient neglected to inform me they have. Many elderly seem to already 
be trying folk medicines & supplements with varying sources and RISKS. They are being 
TARGETS for SNAKE OIL & Mumbo Jumbo far too much for my liking - Sony I got on 
my soap box! 
My nutritional counseling is limited to: (1) General nutritional info commonly accepted - eg 
eating a balanced diet perhaps weighted to fruits & veggies (2) AREDS study: specific 
supplements o& for those diagnosed with non exudative AMD who want to do everything 
possible, that was produced by NEI study, to prevent conversion to exudative AMD & (3) 
Input from my very knowledgable o l o g i s t  (which can largely be state as #2 above!) i.e. 
don't educate on anything that hasn't been validated by good, large scale. Long term study 
by reputable investigators with limited monetary gainlinterest. 
Of all the studies I have looked at, the AREDS study is probably the only good well 
controlled nutritional study looking at AMD and nutrition. This study did not look at lutein or 
zaxanthin. Therefore, a lot of us in the eye care fields are recommending the nutritional 
supplements used in the AREDS study. Certainly there is growing evidence that other 
supplements such as lutein or zeaxanthin may work as well or better, but historical and 
population studies have way too many uncontrolled variables. Therefore, until we get better 
more controlled studies, Lutein and zeaxanthin become just one of the list of supplements 
along with many vitamins, minerals, and other antioxidants. Therefore, the questions 
regarding the recommendations of these compounds are yes they are and can be 
recommended but not exclusive of other supplements. 
Bilbeny enhances circulation in the eye. WE always recommend bilbeny be in a supplement 
or taken separately. CoQlO is also useful in helping the eye to repair oxidative damage. 
Since finding lutein or zeaxanthin as a stand-alone product is very difficult, I would ask 
about this as apart of another supplement in addition to the current questions. 
